Harnessing Pallidal Cell-Type Diversity to Treat Neurological Disorders by Mastro, Kevin
HARNESSING PALLIDAL CELL-TYPE DIVERSITY TO TREAT 
NEUROLOGICAL DISORDERS 
by 
Kevin Joseph Mastro 
Bachelor of Science in Biological Sciences and Psychology, University of Connecticut, 2012 
Submitted to the Graduate Faculty of 
School of Medicine in partial fulfillment 
of the requirements for the degree of 
Doctor of Philosophy 
University of Pittsburgh 
2017 
ii 
UNIVERSITY OF PITTSBURGH 
School of Medicine 
This dissertation was presented 
by 
Kevin Joseph Mastro 
It was defended on 
June 6, 2017 
and approved by 
Robert S. Turner, Ph.D., Professor, Department of Neurobiology 
Susanne E. Ahmari, M.D., Ph. D., Assistant Professor, Department of Psychiatry 
Bita Moghaddam, Professor and Chair, Department of Behavioral Neuroscience, Oregon 
Health and Science University  
Peter L. Strick, Ph.D., Distinguished Professor and Chair, Department of Neurobiology, 
Professor, Department of Psychiatry  
Thomas Wichmann, MD, Professor, Department of Neurology 
Dissertation Advisor: Aryn H. Gittis, Ph.D., Assistant Professor 
iii 
Copyright © by Kevin Joseph Mastro 
2017 
iv 
HARNESSING PALLIDAL CELL-TYPE DIVERSITY TO TREAT NEUROLOGICAL 
DISORDERS 
Kevin J Mastro, B.S 
University of Pittsburgh, 2017
The identification of distinct cell-types within the basal ganglia has played a critical role in 
our understanding of basal ganglia function and the treatment of neurological disorders. As 
discussed in the introduction, the use of transgenic animals and bevy of emerging tools available 
to isolate, manipulate and control distinct populations of neurons have revolutionized 
neuroscience. We are gaining insight into the underlying structure of neural circuits that 
previously was inaccessible. Here, we defined cellular diversity within the globus pallidus 
externa (GPe), a nucleus within the motor-suppressing pathway of the basal ganglia, and 
investigated its contributions to circuit function in health and disease.  
First, we defined two genetically distinct populations of GPe neurons using 
transgenic mouse lines. Utilizing a combination of anatomy and physiology, we found 
significant difference between the two populations of GPe neurons. Briefly, viral expression 
of EYFP revealed that Limhomeobox6 (Lhx6-) and Parvalbumin (PV-) GPe neurons differed 
in their axonal projection patterns as well as electrophysiological properties measured in slice 
recordings. These results provide a new set of tools to target molecularly, anatomically, and 
electrophysiologically distinct  cell-types in the GPe which will enables studies of the 
organization and function of GPe circuits in health and disease. 
Next, we demonstrate that optogenetic interventions that dissociate the activity of 
these two neuronal populations in the GPe – elevating the activity of PV-GPe neurons over 
that of Lhx6-GPe neurons – restores movement in dopamine depleted mice and attenuates 
pathological 
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activity of basal ganglia output neurons for hours beyond stimulation. These results establish the 
utility of cell-specific interventions in the GPe to target functionally distinct pathways, with the 
potential to induce long-lasting recovery of movement despite the continued absence of 
dopamine. 
In the final chapter, we will discuss the evolving and often-controversial field of GPe 
cellular heterogeneity and the future of these neural cell-types. Secondly, we will provide 
potential mechanisms for which GPe cell-types exert profound therapeutic benefit during the 
disease state that could build on current treatments. Taken together, these results demonstrate the 
anatomic, physiological and functional differences that exist within the GPe cell-types and its 
potential to disrupt pathological activity and restore behavior during disease.   
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1.0  INTRODUCTION 
Neural circuits are made up of functionally specialized cell-types whose diversity allow for the 
generation of simple to complex behaviors. With the goal of understanding circuit function for 
the development of novel treatments for disease, the National Institute of Health declared the 
identification of neural cell-types as the leading BRAIN initiative (Jorgenson et al., 2015). Over 
the last decade, the emergence of new technologies has spurred innovative approaches to define 
and manipulate cell-types in the brain. These tools will be featured throughout the dissertation 
while shifting the attention from the identification and manipulation of cell-types (see Reviews 
by (Tye and Deisseroth, 2012, Lerner et al., 2016, Rajasethupathy et al., 2016) to the 
development of cell-type specific therapeutic interventions during disease.  
Here, we will first utilize the basal ganglia as an exemplary circuit that has been 
revolutionized by the identification of neural cell-types and the emerging opportunities to 
harness this diversity to treat neurological disorders. In doing so, we will highlight the use of 
these advanced technologies and the refinement and development of future treatments. Over the 
last 15 years, neuronal cellular resolution has been resolved at an awe-inspiring rate and today 
we stand at the precipice of a most exciting future; to translate basic findings to the development 
of novel, innovative and impactful therapeutic interventions. 
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1.1 ADVANCEMENTS IN CELL-TYPE DEFINITIONS 
At the turn of the 20th century, Santiago Ramon y Cajal and his students produced artistic 
renderings of brain cells that exemplified the diversity in structure of individual cells throughout 
the brain. Utilizing a microscope and the newest staining method (Golgi Stain), they were able to 
visualize individual cells from a host of brain areas. Cajal (Cayal, 1888) postulated that the brain 
is made up of individual cells whose shape, size and overall structure depend greatly on their 
overall location (brain area) and their functional specialization (Yuste, 2015). This relationship 
between structure and function have come to form the fundamental tenants of modern 
neuroscience (Lopez-Munoz et al., 2006); cellular heterogeneity, or cell-types, are the building 
blocks of neural circuits that provide the diversity necessary to produce simple to complex 
behavior. Therefore, major advancements in systems neuroscience are intimately linked to the 
identification of neural cell-types that contribute to function. 
1.1.1 Basal Ganglia Evolution: From Brain Areas to Boxes 
The basal ganglia is a prime example of how advancements in cell-type identification has 
revolutionized the way we understand its function in health and disease. Historically, the large 
striated tissue that sits deep in the brain has drawn an incredible amount of interest for both its 
anatomical differences from cortex and thalamus and its functional implications. Thomas Willis 
was the first to describe the corpus striatum, later termed the basal ganglia, within his Cerebre 
Anatomi (1664) (Willis, 1973), but it was not until the 20th century when the functional and 
anatomical contributions of basal ganglia became clearer (DeLong, 1983, Penney and Young, 
1983, Albin et al., 1989, DeLong, 1990). 
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 During the golden age of basal ganglia research (1960-1990s), there was a proliferation 
of physiology and anatomy studies seeking to understand how information flow navigated this 
subcortical space. Utilizing available neuronal tracing methods and single cell electrophysiology, 
scientists sought to define neuronal populations based on their projections to other nuclei and 
their physiological responses to initiation, maintenance and termination of movements. In a set 
of seminal reviews, the field coalesced on a model of normal and disease states that provided a 
framework to test hypotheses and would go on to dominate the field for decades to come 
(DeLong, 1983, Penney and Young, 1983, Albin et al., 1989, DeLong, 1990).  
As shown in figure 1-1, the striatum is the canonical basal ganglia input structure and 
receives massive inputs from both cortex and thalamus. These excitatory inputs are 
topographically organized and segregated based on their functions (Alexander et al., 1986, Smith 
and Parent, 1986, Ragsdale and Graybiel, 1991, Nelson and Kreitzer, 2014). The striatum then 
funnels this information through two parallel pathways, the direct and indirect. The direct 
pathway represents the projections to the output nuclei of the basal ganglia, globus pallidus 
interna (GPi) and substantia nigra pars reticulata (SNr). The indirect pathway represents the 
polysynaptic route through the globus pallidus externa (GPe) and onward to the subthalamic 
nucleus (STN) before terminating in these same output nuclei. Though obvious anatomical and 
physiological differences existed within many of the basal ganglia nuclei, it was not until the 
advent of transgenic animals and viral manipulations that we gained access to tools that allow for 
delineation of the function of these pathways in health and disease.  
 4 
 
Figure 1-1 Basal Ganglia Circuit under Normal and Parkinsonian conditions 
Weight of black (inhibitory) and grey (excitatory) arrows indicate the presumed activity of each connection. CM, 
centromedian nucleus of thalamus; CMA, cingulate motor area; Dir., direct pathway; D1, D2, dopamine receptor 
subtypes; GPe, external segment of the globus pallidus; GPi, internal segment of the globus pallidus; Indir., indirect 
pathway; M1, primary motor cortex; Pf, parafascicular nucleus of the thalamus; PMC, premotor cortex; PPN, 
pedunculopontine nucleus; SMA, supplementary motor area; SNc, substantia nigra pars compacta; SNr, substantia 
nigra pars reticulata; STN, subthalamic nucleus; VA, ventral anterior nucleus of thalamus; VL, ventrolateral nucleus 
of thalamus. From Galvan et al. (2016), with permission.  
1.1.2 Defining Basal Ganglia Cell-Types 
Major advancements within the field of basal ganglia neuroscience is linked to the identification 
of neural cell-types associated with their differences in gene and protein expression. The first 
major breakthrough occurred within the two striatal projection pathways which are associated 
with distinct molecular markers and receptor expression (Brownstein et al., 1977, Mroz et al., 
1977, Beckstead, 1988, Gerfen et al., 1990). The development of BAC transgenic mice that 
selectively expressed cre-recombinase in either D1- or D2 - dopamine receptor expressing 
neurons associated with the direct and indirect pathway, respectively, provided distinguishable 
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populations of neurons within the striatum for further investigation (Gerfen et al., 1990). For 
example, optogenetic excitation of the direct pathway produced a robust increase in movement. 
In contrast, the indirect pathway activation led to a Parkinsonian-like state, characterized by an 
increase in freezing and slowness of movement (Kravitz et al., 2010, Kravitz and Kreitzer, 
2011). In addition to the gross behavioral contributions, there has been tremendous progress in 
analyzing differences in morphology (Day et al., 2008, Gertler et al., 2008), plasticity (Kreitzer 
and Malenka, 2007, Shen et al., 2008) and their physiological activity during behavior (Cui et al., 
2013) (for thorough review of D1/D2 contributions, see review (Calabresi et al., 2014)).   
 Cell-types exist throughout the basal ganglia, The GPe, a nuclei within the motor-
suppressing indirect pathway, has benefited greatly from expression-based analysis of neurons. 
A set of seminal work identified a population of GPe neurons by their expression of parvalbumin 
(PV) and delineated the anatomical contributions that extended well outside of the canonical 
representation (Bevan et al., 1998, Kita et al., 1999). In Chapter 2, we utilize transgenic mouse 
lines to subdivide the GPe based on the expression of PV or Lim homeobox 6 (Lhx6) that 
uncover differences in their anatomical and physiological properties. Subsequent studies have 
defined the GPe population using additional transgenic animals (Hernandez et al., 2015, Oh et 
al., 2016a) and molecular markers (Mallet et al., 2012, Abdi et al., 2015, Dodson et al., 2015). 
Together, these studies provide definitive evidence for widespread connections of the GPe to 
multiple brain areas both within and outside of the basal ganglia and identifies markers for the 
physiologically distinct populations observed in vivo decades earlier (Delong, 1971).  In 
addition, there has been progress on defining the role of neurons during behavior (Abdi et al., 
2015, Mallet et al., 2016) and decoding their physiology during movement (Dodson et al., 2015).  
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 An obvious limitation for the transgenic or gene expression subdivision is that it lacks a 
direct correlate to the functional output of the given neuronal population. Though optical 
activiation of the direct and indirect pathway led to opposing behavioral output (Kravitz et al., 
2010, Kravitz and Kreitzer, 2011), the intricacies of action selection are much more complex 
(Cui et al., 2013). This suggests that further delineations may be necessary. To gain greater 
insight into the diversity that may contribute to the functional complexity, groups are utilizing 
genome-wide expression profiling of individual cells (Macosko et al., 2015). As seen within the 
cortex (Figure 1-2) (Zeisel et al., 2015, He et al., 2017), basal ganglia (Wallace et al., 2017) and 
brainstem (Kodama et al., 2012), these expression profiles can be plotted and used to find 
common clusters across high dimensional space and aid in the identification of unique genetic 
markers. 
 
Figure 1-2 Molecular census of somatosensory S1 cortex and hippocampal CA1 by unbiased sampling and 
single-cell RNA-seq 
Visualization of nine major classes of cells using t-distributed stochastic neighbor embedding. Each dot is a single 
cell, and cells are laid out to show similarities. Adapted from (Zeisel et al., 2015) Zeisel et al. (2015), with 
permission. 
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To understand neural circuits, we must understand the types of cells that are within them. These 
unbiased sampling methods can be applied across brain areas and provide a database of 
expression profiles for future investigation.  
1.1.3 Input-Output Relationships 
From the earliest investigations of neural circuits, the goal has been to understand the 
relationship of one element to the next. For any given node, we sought to define brain areas 
based on their connectivity within and outside of its local circuit. As discussed in Lerner et al. 
(2016), this provides profound insights into the organization of neural circuits and uncovers 
functionally related sets of neurons. Due to the advancement of retrograde and anterograde 
transported viruses, we have the ability to define these elements for classes of neurons within a 
brain area.  
Many brain areas receive a diverse but distinct set of inputs and the extent to which these 
inputs synapse on individual neurons has often been technically inaccessible, until now. Take for 
example, the renaissance that has occurred recently within the dopamine field. Dopamine 
neurons are a critical component of the basal ganglia circuit and have been shown to be 
instrumental in reward prediction (Schultz, 1998) and often homogenous in their information 
processing (Eshel et al., 2016). Though a massive deal of research has focused on these neurons’ 
role in a wide range of behaviors, there was a significant movement to understand how 
individual dopamine neurons wire into circuits at large. Multiple groups published dissections of 
dopaminergic hubs (Substantia nigra pars compacta and ventral tegmental area) that were based 
on evaluating the input and/or output relationship of single neurons and utilizing these 
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distinctions to understand their function during behavior (Lammel et al., 2011, Watabe-Uchida et 
al., 2012, Beier et al., 2015, Lerner et al., 2015, Menegas et al., 2015). 
Together, these emerging tools that allow for the identification, manipulation and 
analysis of distinct populations of neurons based on expression profiles and connectivity will 
provide invaluable access to cellular diversity. In doing so, we are continuing to break open the 
black box that transform neural signal to simple and complex behaviors.  These same neural cell-
types can then be harnessed to treat neurological disorders and probe the underlying mechanisms 
for symptoms of a wide range of neurological and psychiatric disorders.  
1.2 HARNESSING CELL-TYPES TO TREAT NEUROLOGICAL DISORDERS  
The ultimate goal of defining cell-types is to delineate their functional contributions in health and 
disease. These advancements that will be highlighted within the basal ganglia circuit have 
provided a great opportunity to develop treatments for neurological disorders, including 
Parkinson's disease (PD). Each of the following sections will highlight the most promising cell-
types in the disease pathology and development of therapeutic interventions.  
1.2.1 Parkinson’s Disease 
1.2.1.1 Striatum  
PD is characterized by a progressive loss of dopamine within the basal ganglia that leads to 
devastating motor and cognitive deficits. Under healthy conditions, dopamine regulates the two 
pathways by having opposing functions on their excitability mediated by their differential 
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expression of dopamine receptors (Cepeda et al., 2008). In models of basal ganglia dysfunction 
during PD, the loss of dopamine leads to an imbalance in these striatal pathways and ultimately 
the overactivity of the motor-suppressing indirect pathway and underactivity of motor-
facilitating direct pathway activity (DeLong, 1983, Penney and Young, 1983, Albin et al., 1989, 
DeLong, 1990). Therefore, the prediction from the classic rate model is that activation of the 
motor-facilitating direct pathway should restore motor function.  
In an animal model of PD, optogenetic activation of the direct pathway, mediated by the 
expression of channelrhodopsin within the D1 dopamine receptor-expressing striatal neurons, 
rescued motor function (Kravitz et al., 2010). These findings provided the first evidence for the 
utility of direct pathway manipulation as a therapeutic intervention. Currently, the administration 
of L-aromatic amino acid decarboxylase (L-DOPA), a dopamine precursor, capable of crossing 
the blood brain barrier, has provided a substantial therapeutic benefit. Though effective, 
dopamine replacement therapies are non-specific and prolonged usage leads to L-DOPA induced 
dyskinesia (LID; involuntary movements) in over 80% of Parkinson’s patients. LID are believed 
to be caused by the over-inhibition of indirect pathway projection neurons that leads to decreased 
output of the basal ganglia and a loss of motor control (Obeso et al., 2000). Future treatments can 
capitalize on the distinct population of direct pathway projection neurons by identifying unique 
targets for drug application. By either altering intrinsic properties or increasing specificity of 
drug delivery, the new treatment would rescue motor function while avoiding the negative side 
effects of prolonged dopamine-replacement therapies.    
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1.2.1.2 Subthalamic Nucleus (STN) 
 The STN contains glutamatergic neurons that project to the output nuclei, SNr and GPi, and 
sends a reciprocal connection to the GPe.  The STN receives massive cortical innervation that is 
topographically organized (Parent and Hazrati, 1995). Under healthy conditions, STN neurons 
are high-firing and tonically active where changes in their activity can be related to movement 
(Wichmann et al., 1994, Jaeger et al., 1995, Bergman et al., 1998).  In PD, the STN is implicated 
in the onset and propagation of harmful synchrony and forms a detrimental relationship with the 
reciprocally connected and largely GABAergic, GPe (Wichmann and DeLong, 1996, Bevan et 
al., 2002).  
The STN is one of the major targets for deep brain stimulation (DBS) which includes the 
surgical implantation of electrodes where high frequency (~130 Hz) electrical stimulation 
restores motor function. Similar to the dopamine replacement therapies, DBS struggles with a 
lack of neuronal and pathway specificity and often increase the appearance of other motor, 
sensory and cognitive deficits. Though the cellular mechanisms of DBS are still unclear, there 
has been work to localize optimal STN placement and alternatives to probing its activity. Baron 
et al. (2002) found that focal inactivation of the STN or GPi were sufficient for amelioration of 
Parkinsonian motor deficits. Moreover, the targeting of DBS electrodes is most effective within 
the sensorimotor region of either the STN or GPe (Wichmann and DeLong, 2016). Interestingly, 
optical activation of afferents to the STN provided a strong amelioration of PD deficits that was 
not observed upon direct activation of the STN neurons (Gradinaru et al., 2009). Together, these 
data indicate that modulation of the sensorimotor pathway, irrespective of STN neuronal 
activation, is sufficient to rescue motor function in animal models of PD. Future treatments may 
work to selectively alter the activity within this region of the STN by improving targeting of 
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DBS electrodes or by way of transcranial magnetic stimulation (TMS) of cortex. Recently, 
Udupa et al. (2016) paired TMS of the motor cortex (M1) and DBS of the STN and showed an 
increase in the cortical plasticity at the M1-STN node. Therefore, this study provided the proof 
of principle for the development of protocols that would exploit the LTP-like effects of TMS on 
M1-STN connection while paired with DBS. By doing so, it would reduce the amount of time 
necessary for DBS stimulation which must remain on to gain the therapeutic benefits. 
 
1.2.1.3 Globus Pallidus Externa (GPe) 
The GPe is in the motor-suppressing indirect pathway and has widespread connections within 
and outside of the basal ganglia. The striatum and STN constitute two of the greatest sources of 
inputs. The GPe and STN are implicated in PD pathological activity and the disruptions of which 
corresponds to motor recovery.  In PD, the activity of the GPe is severely diminished (Nini et al., 
1995, Plenz and Kital, 1999, Raz et al., 2000, Bevan et al., 2002, Levy et al., 2002, Terman et al., 
2002). Like the STN, the GPe is a possible target for successful DBS (Johnson et al., 2012, Vitek 
et al., 2012), but experimental attempts to restore the activity of the GPe, globally, did not 
provide a therapeutic benefit (Chan et al., 2011, Mastro et al., 2017).  
In Chapter 3, we harness cell-types within the GPe to disrupt pathological activity and 
restore motor function (Mastro et al., 2017). Briefly, upon activation of PV-GPe or the inhibition 
of Lhx6-GPe neurons in a dopamine-depleted animal, there is the induction of a persistent and 
long-lasting recovery in motor function. Moreover, these successful manipulations attenuate 
pathological activity in the output nucleus of the basal ganglia that persists for hours and hours 
after stimulation. In Chapter 4, there will a discussion focused on the potential mechanism for 
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the long-lasting recovery. Including a review of a new DBS protocol that has been shown to 
destabilize the BG network and provide relief for hours to days after treatment.  
Overall, these results suggest that the development of future treatments to persistently 
disrupt pathological activity is first, possible and second, may hinge on preferentially increasing 
the activity of PV-GPe neurons relative to other GPe neurons.  Current work is focused on 
highlighting the differences between the two populations that may be used to dissociate their 
activity. For example, PV- and Lhx6-GPe neurons project differently to the STN (Mastro et al., 
2014) and may provide an opportunity through targeting of the DBS electrodes for a greater 
relief of motor dysfunction. Due to the similar proportion of PV-GPe neurons in humans to that 
in mice (Hardman and Halliday, 1999), directly targeting this population of neurons represents 
another translational approach. Here, we could capitalize on the electrophysiological differences 
that exist between PV-GPe neurons and other populations (Mastro et al., 2014, Abdi et al., 2015, 
Glajch et al., 2016) that would increase the excitability and restore the activity of these neurons. 
Together, these results support the development of potential treatments that utilize cell-type 
specific GPe interventions that can persistently disrupt pathological activity and restore motor 
function.  
1.3 SUMMARY AND AIMS OF DISSERTATION 
In summary, the identification of neural cell-types has revolutionized neuroscience and provides 
new opportunities to harness these differences and treat neurological disorders. The basal ganglia 
represent a circuit that is constantly evolving and has benefited greatly from the identification of 
neural cell-types.  This dissertation represents the steps taken to break open one critical node 
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within the basal ganglia, the GPe. In the following chapters, we will highlight the transgenic 
animals that provided unparalleled access to two partially-overlapping populations of GPe 
neurons. This study establishes the differences that exist between PV- and Lhx6-GPe neurons 
along a range of factors: topography, physiological properties (ex vivo) and axonal projections. 
Secondly, we will demonstrate the utility of cell-type specific interventions in a dopamine 
depleted mouse and its ability to restore motor function and disrupt pathological activity in the 
basal ganglia circuit.  Lastly, we will explore the two major themes within this document; GPe 
cellular heterogeneity and the potential mechanisms underlying cell-type specific rescue of 
motor function during disease. 
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2.0  TRANSGENIC MOUSE LINES SUBDIVIDE EXTERNAL SEGMENT OF THE 
GLOBUS PALLIDUS (GPE) NEURONS AND REVEAL DISTINCT GPE OUTPUT  
Cell-type diversity in the brain enables the assembly of complex neural circuits, whose 
organization and patterns of activity give rise to brain function. However, the identification of 
distinct neuronal populations within a given brain region is often complicated by a lack of 
objective criteria to distinguish one neuronal population from another. In the external segment of 
the globus pallidus (GPe), neuronal populations have been defined using molecular, anatomical, 
and electrophysiological criteria, but these classification schemes are often not generalizable 
across preparations, and lack consistency even within the same preparation. Here, we present a 
novel use of existing transgenic mouse lines, Lhx6-Cre and PV-Cre, to define genetically distinct 
cell populations in the GPe that differ molecularly, anatomically, and electrophysiologically. 
Lhx6-GPe neurons, which do not express PV, are concentrated in the medial portion of the GPe. 
They have lower spontaneous firing rates, narrower dynamic ranges, and make stronger 
projections to the striatum, and SNc compared to PV-GPe neurons. In contrast, PV-GPe neurons 
are more concentrated in the lateral portions of the GPe. They have narrower action potentials, 
deeper AHPs, and make stronger projections to the STN and parafascicular nucleus of the 
thalamus. These electrophysiological and anatomical differences suggest that Lhx6- and PV-GPe 
neurons participate in different circuits with the potential to contribute to different aspects of 
motor function and dysfunction in disease. 
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2.1 INTRODUCTION 
The basal ganglia are a set of subcortical nuclei that play an important role in facilitating 
voluntary movement in health and disease (Albin et al., 1989, DeLong, 1990). The basal ganglia 
are thought to control movement through the coordinated activity of the direct and indirect 
pathways that have opposite effects on movement (Alexander and Crutcher, 1990, Smith et al., 
1998a, Kravitz et al., 2010). The external segment of the globus pallidus (GPe) is a central 
nucleus in the motor-suppressing indirect pathway, which receives inputs from the striatum, 
subthalamic nucleus (STN) and parafascicular nucleus of the thalamus (pf) (Robledo and Feger, 
1990, Kincaid et al., 1991, Kita and Kitai, 1991, Parent and Hazrati, 1995). In vivo recordings 
have shown that GPe neurons fire independently (Nini et al., 1995), with firing rates that are 
characterized by complex temporal patterns and low correlation during movement (Delong et al., 
1985, Wichmann et al., 1994, Jaeger et al., 1995, Bergman et al., 1998).  
Overall, the specific contributions of the GPe to basal ganglia function are not well 
defined, but the GPe has been strongly implicated in the onset and maintenance of motor 
dysfunction in movement disorders such as dystonia and Parkinson’s disease (Lozano et al., 
2000, Kita, 2007, Obeso et al., 2008). Most notably, the activity of GPe neurons in patients 
suffering from Parkinson’s disease is reduced and the synchronization of GPe neurons is thought 
to contribute to pathological oscillations (Nini et al., 1995, Plenz and Kital, 1999, Raz et al., 
2000, Bevan et al., 2002, Levy et al., 2002, Terman et al., 2002). Consistent with the hypothesis 
that oscillations contribute to motor dysfunction, deep brain stimulation of the GPe has been 
shown to relieve Parkinsonian motor symptoms in humans (Vitek et al., 1998, Yelnik et al., 
2000, Vitek et al., 2004, Vitek et al., 2012). 
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Progress in linking activity of GPe neurons to behavior has been complicated by the fact 
that the GPe contains a heterogeneous population of neurons that likely contribute differentially 
to motor function in healthy and diseased individuals. Anatomical studies have shown that GPe 
neurons project to a number of brain areas, but most of these projections are given little 
consideration in models of basal ganglia function (Parent et al., 1983, Smith and Bolam, 1989, 
Kita and Kitai, 1994, Smith et al., 1998b, Sato et al., 2000). For example, the identification of 
pallidostriatal neurons using tracing techniques in rodents and primates suggests a complexity of 
neural circuit organization in the GPe that has long been underappreciated (Kita and Kitai, 1994, 
Bevan et al., 1998, Kita et al., 1999, Sato et al., 2000, Mallet et al., 2012). Attempts have been 
made to classify  cell-types in the GPe, but these criteria are often difficult to generalize across 
preparations (Nambu and Llinas, 1994, Cooper and Stanford, 2000, Kita, 2007, Deister et al., 
2013), rely on postmortem  cell-type identification (Hoover and Marshall, 1999, Sato et al., 
2000, Hoover and Marshall, 2002), or rely on activity in disease states (Mallet et al., 2012).  
Here, we utilize transgenic mouse lines to define two genetically distinct, non-
overlapping populations of GPe neurons in healthy rodents. Viral expression of EYFP revealed 
that Lhx6- and PV-GPe neurons differed in their axonal projection patterns as well as 
electrophysiological properties measured in slice recordings. These results provide a new set of 
tools to target molecularly, anatomically, and electrophysiologically distinct  cell-types in the 
GPe which will enables studies of the organization and function of GPe circuits in health and 
disease. 
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2.2 MATERIALS AND METHODS 
2.2.1 Mouse Lines and Tissue Processing 
All procedures were carried out in accordance with the guidelines from the NIH and with 
approval of the CMU IACUC. Male and female heterozygous 4-8 week-old mice on a C57BL/6J 
background were used for experiments. Lhx6-GPe neurons were targeted using Lhx6-GFP 
(GENSAT, www.gensat.org) or Lhx6-Cre (Fogarty et al., 2007) mouse lines. PV-GPe neurons 
were targeted using a Pvalb-2A-Cre mouse line (Madisen et al., 2010).  
 For immunohistochemistry, mice were perfused transcardially with phosphate buffered 
saline (PBS), followed by 4% paraformaldehyde in PBS. Brains were removed and drop-fixed 
with the same fixative at 4°C for 24 h. After rising with PBS, brains were transferred to 30% 
sucrose in PBS and stored at 4°C for at least 24 h before sectioning. Tissue was sectioned in 30 
µm sections, blocked with 10% normal donkey serum and permeabilized with 0.5% Triton X-
100 for 1 h. Primary antibody incubations were performed at 4°C for 24 h, using either rabbit 
anti-GFP (1:500, Millipore), chicken anti-GFP (1:1000, Aves), mouse anti-NeuN (1:1000, 
Millipore), rabbit anti-TH (1:1000), or at 4°C for 48 h when using rabbit anti-PV (1:1000, 
Swant). Primary antibodies were detected with Alexa Fluor 488-conjugated goat anti-chicken 
(1:500, Vector Laboratories), Alexa Fluor 488-conjugated goat anti-rabbit (1:500, Vector 
Laboratories), Alexa Fluor 568-conjugated donkey anti- rabbit (1:500, Vector Laboratories), 
Alexa Fluor 568-conjugated donkey anti-mouse (1:500, Vector Laboratories), Alexa Fluor 647-
conjugated donkey anti-rabbit (1:500, Vector Laboratories), or Alexa Fluor 647-conjugated 
donkey anti-mouse (1:500, Vector Laboratories), incubated for 2 h at room temperature.  
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 For processing of Fluoro-Gold (FG) labeling, primary antibody incubations were 
performed at 4°C for 48 h using rabbit anti-FG (1:3000, Fluorochrome). Primary antibody was 
detected using Alexa Fluor 647-conjugated donkey anti-rabbit (1:500, Vector Laboratories) for 3 
h at room temperature. 
2.2.2 Animal Surgery and Viral Injections 
Injections of AAV2-DIO-EYFP or AAV5-DIO-ChR2-EYFP (used for electrophysiology), 
produced at the University of North Carolina (Vector Core Facility) were made in 4-5 week-old 
PV-Cre or Lhx6-Cre transgenic mice. Anesthesia was induced using 50 mg/mL ketamine / 15 
mg/mL xylazine and maintained throughout surgery using 2% isofluorane. Mice were placed in a 
stereotaxic frame (Kopf Instruments), the scalp was opened and bilateral holes were drilled in the 
skull (0.27-0.30 mm anterior, 2.1-2.2 mm lateral from Bregma). 150 – 200 nL of virus was 
injected with a Nanoject (Drummond Scientific) through a pulled glass pipet (tip diameter ~30 
µm) whose tip was positioned 3.70 mm below the top of the skull.  To prevent backflow of virus, 
the pipet was left in the brain for 5 min after completion of the injection. Animals were housed 
for at least 2 weeks following injection to allow time for viral expression.  
 Injections of Fluoro-Gold were done using the same surgical procedures, but bilateral 
holes were drilled over the striatum (1.0 mm anterior, 2.3 mm lateral from Bregma) and 1 µL of 
Fluoro-Gold (0.5% in saline, Fluorochrome) was injected 3.7 mm below the surface of the skull 
using a syringe pump (0.2 µL/min; Genietouch). Mice were perfused two weeks following 
injections and tissue was prepared as described above. 
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2.2.3 Fluorescence Quantification  
Quantification of axonal projection patterns of Lhx6- and PV-GPe neurons was carried out in 
sagittal sections from hemispheres where GPe injections met the following criteria: viral 
expression within the GPe was strongest within the central plane of analysis (Lateral 1.56 mm, 
Figure 114 (Paxinos, 2004), and labeled cell bodies were observed throughout the full rostral-
caudal, dorsal-ventral, and medial-lateral extent of the structure. Analyses were carried out in 7 
sagittal planes: (Lateral from bregma, mm) 3.12, 2.76, 2.04, 1.56, 1.20, 0.84, and 0.48 (Paxinos, 
2004). Hemispheres in which there was significant spillover of virus and EYFP expression in 
neighboring structures, such as the reticular thalamic nucleus, ventral palladium, and striatum 
were excluded from analysis. To aid in visualization of axonal projections from the GPe, EYFP 
signal was enhanced with an immunostain against GFP. Epifluorescent images were taken at 25x 
magnification in seven sagittal slices of each brain and the same sectional planes across animals 
were used for analyses. To control for differences in viral expression or antibody retrieval, data 
from each animal was normalized to the fluorescence intensity in the GPe during analysis. 
Images were analyzed offline utilizing the pixel intensity-measuring tool on ImageJ. Data were 
quantified by averaging the pixel intensity within and across each brain structure. On average, 
three 100 px x 100 px (75 µm x 75 µm: Area = 5625 µm2) squares were quantified in each of the 
images. The mean of all pixel intensities designated as within a single structure was found and 
normalized to GPe expression of each animal. For example, dorsolateral striatum was identified 
in three planes of section (Lateral from Bregma, mm: 3.12, 2.76, and 2.04). Three measures of 
pixel intensity were taken by randomly placing the 75 x 75 µm square throughout the image. The 
mean of each image was taken and then averaged across the three planes of section to identify 
the average pixel intensity of dorsolateral striatum. Finally, the average was normalized to the 
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brightest GPe expression found within the animal, which was located in the central plane of 
analysis (Lateral 1.56 mm, Figure 114). Striatum, RT, GPi, BLA, PSTh and pf were analyzed 
using the method described above. 
Due to the irregular shape of the STN and the ease at which the STN borders could be 
identified at 25x magnification, ImageJ hand draw tool was used to measure average pixel 
intensity of the entire structure. Similar to other structures, the STN was identified in more than 
one plane of section, and the pixel intensity from each plane was averaged and then normalized 
to GPe expression. 
In the case of the substantia nigra, a tyrosine hydroxylase (TH) stain was used to define 
the borders between dopamine neurons of the pars compacta and the non-dopaminergic 
(GABAergic) neurons of the pars reticulata. GFP and TH expression was sequentially imaged in 
the GPe and SN using the epifluorescent microscope at 10x-magnification. For ImageJ analysis, 
zones were clearly defined using TH expression as a marker for the pars compacta and utilizing 
the hand draw tool described above. These zones were then overlaid on the images showing GFP 
expression and the average pixel intensity was found. The average across sections was taken and 
normalized to GPe expression. Differences in normalized fluorescence intensities were compared 
using a t-test. 
 Results of Fluoro-Gold retrograde labeling were analyzed in 2-4 sections each from three 
PV mice (PV-Cre x Ai3 or PV-Cre x Ai9) and three Lhx6 mice (Lhx6-GFP). GPe sections were 
magnified to 63X on an epifluorescent microscope. The number of FG+ neurons in an 225 µm x 
175 µm square of tissue were counted and scored as Lhx6+, PV+, or neither. Populations of FG+ 
neurons that were either Lhx6 or PV were compared using a Fisher's Exact Test. 
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2.2.4 Three-Dimensional Sholl’s Analysis 
To quantify the selective innervation of striatal fast-spiking striatal interneurons (FSIs) by Lhx6- 
and PV-GPe neurons, a three-dimensional Sholl’s analysis was performed as described 
previously (Chattopadhyaya et al., 2004). Briefly, tissue from mice expressing EYFP in Lhx6- or 
PV-GPe neurons was immunostained for PV and NeuN to identify FSIs and medium spiny 
neurons in the striatum, respectively. Although NeuN does not selectively stain MSNs, MSNs 
make up 95% of neurons in the striatum, so for the purposes of this analysis, we assumed that 
NeuN+/PV- neurons were most likely MSNs. Confocal z-stack images of presumed striatal FSIs 
and MSNs were taken at 63x-magnification and channels were sequentially imaged to avoid 
bleedthrough. Stacked images were merged using ImageJ and concentric circles of increasing 
diameter (2 m) were drawn from the center of each identified neuron. Innervation was 
quantified as the number of axonal varicosities counted in each circle.  
2.2.5 Electrophysiological Recordings 
Parasagittal sections (300 m thickness) containing the GPe or parafascicular nucleus were 
prepared from brains of 5-8 week-old mice.  Lhx6-GPe neurons were targeted in slices from 
Lhx6-GFP mice, Lhx6-Cre mice injected in the GPe with AAV2-DIO-EYFP, or Lhx6-Cre mice 
crossed to the reporter strains Ai9 (red) or Ai3 (green) (Jackson Laboratories). PV-GPe neurons 
were targeted in slices from PV-Cre mice injected in the GPe with AAV2-DIO-EYFP or PV-Cre 
crossed to Ai9 or Ai3 reporter strains.  
Slices were prepared on a Leica VT1200 vibratome in an ice-cold Hepes cutting solution (in 
mM): 92 NaCl, 2.5 KCl, 1.2 NaH2PO4, 30 NaHCO3, 20 Hepes, 25 glucose, 5 sodium ascorbate, 
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2 thiourea, 3 sodium pyruvate, 10 MgCl2, and 0.5 CaCl2. Slices were allowed to recover for 15 
min at 33ºC in a chamber filled with NMDG-Hepes recovery solution (in mM): 93 NMDG, 2.5 
KCl, 1.2 NaH2PO4, 30 NaHCO3, 20 Hepes, 25 glucose, 10 MgSO4, 0.5 CaCl2, 5 sodium 
ascorbate, 2 thiourea, 3 sodium pyruvate. After 15 min, slices were held at room temperature for 
at least 1 h before recording in a holding solution that was similar to the Hepes cutting solution 
but with 1 mM MgCl2 and 2 mM CaCl2. Recordings were made at 33ºC in carbogenated ACSF 
(in mM): 125 NaCl, 26 NaHCO3, 1.25 NaH2PO4, 2.5 KCl, 12.5 glucose, 1 MgCl2, and 2 CaCl2. 
For recordings of intrinsic excitability, 50 µm picrotoxin and 5 µM DNQX were included in the 
bath to block fast inhibitory and excitatory transmission, respectively. 
 Data were collected with a MultiClamp 700B amplifier (Molecular Devices) and ITC-18 
A/D board (HEKA) using Igor Pro software (Wavemetrics) and custom acquisition routines 
(Recording Artist, Richard C. Gerkin). Current-clamp recordings were filtered at 10 kHz and 
digitized at 40 kHz; voltage clamp recordings were filtered at 2 kHz and digitized at 10 kHz. 
Electrodes were made from borosilicate glass (pipette resistance, 2 – 4 M). The internal solution 
for current clamp recordings consisted of (in mM): 130 KeMSO3, 10 NaCl, 2 MgCl2, 0.16 
CaCl2, 0.5 EGTA, 10 Hepes, 2 Mg-ATP, 0.3 Na-GTP and the internal for voltage clamp 
recordings consisted of (in mM): 120 CsMeSO3, 15 CsCl, 8 NaCl, 0.5 EGTA, 10 Hepes, 2 Mg-
ATP, 0.3 Na-GTP, 5 QX-314.  
 Differences in electrophysiological parameters were compared using a Wilcoxon non-
parametric test. Action potential half-width was calculated as the width of the action potential, 
measured at a point halfway between threshold and AP peak. AP threshold was defined as the 
voltage at which the acceleration in voltage exceeded 3 × 105 V/s/s. Maximum firing rate was 
measured as the average maximum firing rate over a 1 s step that could be sustained without 
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entering depolarization block. Input resistance was calculated in voltage clamp as the deviation 
from the holding current caused by a 5 mV hyperpolarizing step. The change in current was 
calculated as the difference between baseline holding current and the average current during the 
last 10 ms of the 40 ms hyperpolarizing voltage step. Whole-cell capacitance was calculated by 
integrating the area under the transient following a 5 mV hyperpolarizing voltage step from the 
holding potential, −80 mV. The holding current was subtracted before integrating. 
2.3 RESULTS 
2.3.1 Distinct Neuronal Subpopulations Identified in Lhx6 and PV Transgenic Mouse 
Lines 
Transgenic mouse lines were used to identify two distinct subpopulations of neurons in the GPe. 
In the first transgenic line, Pvalb-2a-Cre (PV-Cre) (Madisen et al., 2010), gene expression was 
driven under the promoter for paravalbumin (PV), a calcium binding protein found in 
GABAergic neurons in the CNS. In the second transgenic line, Lhx6-Cre (Fogarty et al., 2007) 
or Lhx6-GFP (Gensat), gene expression was driven under the promotor for Lhx6, a homeobox 
protein found in a subset of GABAergic neurons in the brain (Marin et al., 2000, Cobos et al., 
2006). An immunostain against PV in tissue from an Lhx6-GFP mouse revealed non-overlapping 
populations of neurons in the GPe (Fig. 2-1A). Lhx6- and PV-GPe neurons each accounted for 
about 1/3 of NeuN+ neurons in the GPe.  Lhx6-GPe neurons made up 34% (1030/3517) of 
NeuN+ GPe neurons while PV-GPe neurons made up 29% (1149/3517), with only 2% (54/3517) 
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of NeuN+ GPe neurons expressing both (Fig. 2-1B). Neurons were scored as positive for Lhx6 
or PV if pixel intensity was >10x background.  
 
Figure 2-1 Identification and distribution of Lhx6- and PV-GPe neurons in transgenic mice.  
A. Epifluorescent image from the GPe of an Lhx6-GFP mouse immunostained for PV showing two distinct 
populations of Lhx6+/PV- (green) and Lhx6-/PV+ (red) neurons. B. Graph showing the percentage of neurons that 
are Lhx6+/PV-, Lhx6-/PV+, both, or other throughout the GPe. Error bars are SEM. C. Schematic depiction of cell-
type gradient found along the medial-lateral axis. Dotted lines divide the GPe into the three zones used for analysis 
of the medial-lateral axis. Lhx6 population (green) is found primarily in the medial portion while PV population 
(red) is found more laterally. D. Graph of the percentage of each cell population located within the three divisions 
along the medial-lateral axis. Error bars are SEM. E. Epifluorescent images of medial and lateral sections of the GPe 
showing Lhx6-GFP (green) or PV immunofluorescence (red). Scale bar, 200 µm. 
 
Because the fraction of PV-GPe neurons observed with immunostaining was lower than 
what has been reported in other species, we utilized a second, genetic approach to quantify the 
fraction of PV-GPe neurons. PV-Cre mice were crossed to fluorescent reporter mice (Ai3) and 
fixed sections from these animals were immunostained with NeuN and PV. Consistent with our 
immunohistochemistry data, genetically-identified PV-GPe neurons were less than half of all 
GPe neurons (41%, 235/571), and 78% (1226 / 1544) of genetically-defined PV-GPe neurons 
were immunopositive for PV.  
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To quantify the spatial distribution of Lhx6 and PV neurons within the GPe, cells were 
counted along medial-lateral, dorsal-ventral, and rostral-caudal axes. No gradients were observed 
along the rostral-caudal and dorsal-ventral axes, but opposing gradients were observed along the 
medial-lateral axis (Fig. 2-1C-E). Lhx6-GPe neurons were most concentrated in the medial 
portions of the GPe and decreased in concentration from medial to lateral, while PV-GPe 
neurons were most concentrated in the lateral and less concentrated in the more medial portions 
of the GPe. 
2.3.2 Lhx6- and PV-GPe Neurons Express Different Baseline Firing Rates 
To determine whether Lhx6- and PV-GPe neurons correspond to electrophysiologically distinct 
subpopulations, neurons of each  cell-type were targeted for recording in acute slices from 5-8 
week-old Lhx6 or PV transgenic mice. To determine the rates of intrinsic pacemaking in each  
cell-type, 50 µM picrotoxin and 5 µM DNQX were bath applied to block fast inhibitory and 
excitatory transmission, respectively. In the cell attached configuration, both  cell-types fired 
tonically with low inter-spike variability (CVLhx6 = 0.31 ± 0.39, n = 25 vs. CVPV = 0. 22 ± 0.25, n 
= 20; p = 0.1) (Fig. 2-2A). On average, PV-GPe neurons exhibited faster extracellular firing rates 
than Lhx6-GPe neurons (Lhx6 = 34.2 ± 33.2 Hz, range 1.3 - 142 Hz vs. PV = 64.4 ± 34.3 Hz, 
range 9.2 - 131 Hz; p = 0.001) (Fig. 2-2B). To ensure that extracellular firing rates were not 
influenced by the voltage clamp recording configuration or the gigaohm seal, we recorded 
extracellular firing rates in a second population of neurons using loose patch in cell attached 
recording mode. Once again, PV-GPe neurons were found to have significantly higher 
extracellular firing rates than Lhx6-GPe neurons (Lhx6 = 28.9 ± 17.7 Hz, range 3.9 - 55.2 Hz, n 
= 20 vs. PV = 66.1 ± 39.0 Hz, range 14.8 - 140 Hz, n = 17; p < 0.0001). In the whole cell-
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recording configuration, spontaneous firing persisted in 20/27 PV-GPe neurons but in only 18/38 
Lhx6-GPe neurons (Fig. 2-2C). Spontaneous firing rates were measured within 5 minutes of 
break-in because spontaneous firing rates tended to run down over the duration of a recording. 
Spontaneous firing rates recorded in whole cell configuration were also significantly faster in 
PV-GPe neurons compared to Lhx6-GPe neurons (Lhx6 = 7.8 ± 14.2 Hz, n = 38 vs. PV = 28.4 ± 
24.9 Hz, n = 27; p = 0.0003) (Fig. 2-2D).  
 
Figure 2-2 Differences in baseline firing rates of Lhx6- and PV-GPe neurons  
A. Representative traces of cell attached recordings from Lhx6 (left) and PV (right) neurons, showing tonic firing 
with low inter-spike variability. B. Extracellular firing rates recorded for the population of PV-GPe neurons were 
significantly faster than those for Lhx6-GPe neurons. C. Representative traces of spontaneous firing in whole cell 
recording configuration for Lhx6 (left) and PV (right) neurons. D. Spontaneous firing rates recorded for the 
population of PV-GPe neurons were significantly faster than those for Lhx6-GPe neurons. E. Responses of 
representative Lhx6 (left) and PV (right) neurons to 3 s hyperpolarizing steps in current clamp. F. Amplitude of sag 
current plotted as a function of Vm reached immediately following the hyperpolarizing step for neurons in E. G-H. 
Maximum amplitude of the sag current (G) and its linear relationship to Vm (H), recorded for the population of 
Lhx6- and PV-GPe neurons. 
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 Because autonomous pacemaking in GPe neurons relies in part on hyperpolarization-
activated, cyclic nucleotide-gated cation (HCN) channels (Chan et al., 2004), we hypothesized 
that differences in intrinsic firing rates between Lhx6- and PV-GPe neurons might arise from 
differences in hyperpolarization-activated currents (Ih). To measure Ih, Lhx6- and PV-GPe 
neurons were given 3 s hyperpolarizing current injections of increasing magnitude (Fig. 2-2E). In 
the current clamp recording configuration, hyperpolarization resulted in an Ih-mediated 
rectification of the membrane potential, often referred to as a membrane potential “sag”, which 
increased monotonically as a function of membrane potential (Fig. 2-2F). Surprisingly, we 
observed no difference in the maximum sag recorded in Lhx6- and PV-GPe neurons (Lhx6 = 
16.1 ± 7.0 mV, n = 35 vs. PV = 13.8 ± 5.5 mV, n = 22; p = 0.22) (Fig. 2-2G) and no difference in 
the slope of the monotonic relationship between sag and membrane potential (Lhx6 = -0.264 ± 
0.14 vs. PV = -0.259 ± 0.13; p = 0.77) (Fig. 2-2H). These results suggest that differences in Ih 
expression are unlikely to account for differences in intrinsic firing rates of Lhx6- and PV-GPe 
neurons, but do not rule out this possibility entirely. 
2.3.3 Lhx6- and PV-GPe Neurons Have Different Passive and Active Membrane 
Properties 
Variability in a number of passive and active membrane properties has been reported across GPe 
neurons, including resting membrane potential, firing rate adaptation, and action potential shape 
(Nambu and Llinas, 1994, Cooper and Stanford, 2000). To determine whether passive membrane 
properties vary systematically between Lhx6- and PV-GPe neurons, neurons were held in 
voltage clamp (-80 mV) and given brief hyperpolarizing steps (-5 mV, 100 ms). Figure 3A 
shows the response of a representative Lhx6-GPe neuron and a representative PV-GPe neuron. 
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Input resistance, calculated from the current flowing during the hyperpolarizing step, was 
significantly greater in Lhx6- relative to PV-GPe neurons (300 .6 ± 168 MΩ, n = 38 vs. 170 ± 88 
MΩ, n = 28; p = 0.0007) (Fig. 2-3B). Whole cell capacitance, calculated as the integral under the 
transient (Fig. 2-3A, inset), was significantly greater in PV-GPe relative to Lhx6-GPe neurons 
(241 ± 113 pF, n = 28 vs. 164 ± 65 pF, n = 38; p = 0.002) (Fig. 2-3C). Because capacitance is 
proportional to the surface area of a neuron, these results suggest that PV-GPe neurons are 
larger, or have more extensive dendritic arborizations than Lhx6-GPe neurons.  
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Figure 2-3 Differences in passive and active membrane properties of the Lhx6- and PV-GPe neurons in slice 
recordings.  
A. Voltage clamp recordings (Vhold = -80 mV) showing the response of representative Lhx6-and PV-GPe neurons 
after a brief hyperpolarizing step (-5 mV, 100 ms). Inset shows the difference in membrane time constant (τ). Scale 
bar, 100 pA, 2 ms. B-C. Population data showing significant differences in input resistance (B) and whole cell 
capacitance (C) between Lhx6- and PV-GPe neurons. D. Instantaneous firing rates from representative Lhx6 (left) 
and PV (right) neurons in response to 1 s depolarizing current injections of increasing amplitude until neurons 
entered depolarization block. For Lhx6-GPe neuron, firing rates are shown in response to injections of 0 pA (no 
spikes), 200 pA, 400 pA, 800 pA, 1400 pA. For PV-GPe neuron, firing rates are shown in response to injections of 0 
pA, 400 pA, 800 pA, 1200 pA, 2700 pA. E. Average spike waveforms of representative Lhx6- and PV-GPe neurons 
firing at 5-10 Hz.  F. Scatter plot of action potential width vs. maximum firing rate for the population of Lhx6- and 
PV-GPe neurons. These parameters varied continuously across the population, but were significantly different 
between Lhx6- and PV-GPe neurons. 
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 To compare active membrane properties of Lhx6- and PV-GPe neurons, the recording 
configuration was switched to current clamp and neurons were driven to fire with 1 s 
depolarizing current steps. The amplitude of injected current was increased incrementally until a 
neuron reached its maximum firing rate, defined as the average firing rate sustained over the 1 s 
step without entering depolarization block (Fig. 2-3D). The maximum firing rate of PV-GPe 
neurons was significantly greater than that of Lhx6-GPe neurons (347 ± 80 Hz, n = 38 vs. 248 ± 
80 Hz, n = 27; p < 0.0001). Maximum firing rate was well correlated with action potential width 
(Fig. 2-3F), and PV-GPe neurons had narrower action potentials than Lhx6-GPe neurons (0.28 ± 
0.09 ms, n = 27 vs. 0.37 ± 0.11 ms, n = 38; p = 0.003) (Fig. 2-3E). Although action potential 
widths and maximum firing rates varied continuously across the population of GPe neurons, 
Lhx6-GPe neurons clustered more at one end of the distribution while PV-GPe neurons clustered 
more at the other end of the distribution (Fig. 2-3F). Using maximum firing rate as the sole 
criteria enabled Lhx6- and PV-GPe neurons to be distinguished with ~75% accuracy (78% of 
PV-GPe neurons had maximum firing rates > 300 Hz and 72% of Lhx6-GPe neurons had 
maximum firing rates < 300 Hz). This degree of overlap emphasizes the importance of utilizing 
genetic markers to segregate  cell-types in the GPe. A list of additional parameters quantifying 
the firing properties of Lhx6- and PV-GPe neurons is provided in Table 1. 
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Table 1. Intrinsic Properties of GPe Neurons 
 
2.3.4 Projections of Lhx6- and PV-GPe Neurons to the STN 
To study the axonal projection patterns of Lhx6- and PV-GPe neurons, we utilized a Cre-
dependent adenoassociated virus (AAV2) to express EYFP selectively in one neuronal 
population or the other. Virus was stereotaxically injected into the GPe of PV-Cre and Lhx6-Cre 
transgenic mice and tissue was processed and analyzed two weeks later. To control for variations 
in viral expression or immunolabeling across mice, fluorescence intensities in target brain 
regions were normalized to fluorescence intensity in the GPe of the same animal (see methods). 
Fluorescence intensities measured in the GPe ranged from 146-249 a.u. but were not 
significantly different between Lhx6 and PV mice (Lhx6 = 216 ± 27 a.u., n = 4 vs. PV = 202 ± 
51 a.u., n = 4; p = 0.6) (Fig. 2-4C). To confirm that fluorescence intensity varied similarly as a 
function of axonal density in both mouse lines, we measured the fluorescence intensity of a small 
region of tissue (143 µm2) and manually counted the number of axonal varicosities present. In 
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both mouse lines, a linear relationship was observed between fluorescence intensity and number 
of boutons, quantified in brain areas receiving low (striatum), medium (SNr), and high (STN) 
amounts of axonal projections (Fig. 2-4D). Therefore, we were able to use the normalized 
fluorescence intensity to compare the density and pattern of axonal projections from Lhx6- and 
PV-GPe neurons to many different brain regions.  
 The first brain region investigated was the subthalamic nucleus (STN), the canonical 
target of the GPe (Fig. 2-4A). Both Lhx6 and PV-GPe neurons densely innervated the STN, but 
innervation from PV-GPe neurons was significantly greater than innervation from Lhx6-GPe 
neurons (Lhx6 = 59.9 ± 13.6 a.u., n = 4 vs. PV = 96.2 ± 11.3 a.u., n = 4; p = 0.0063) (Fig. 2-4B). 
This difference in innervation density was largely due to the unique patterning of Lhx6 
projections to the STN. Unlike PV-GPe projections, which were evenly distributed throughout 
the extent of the nucleus, Lhx6-GPe projections were clustered around the periphery of the STN 
and did not target the central portion of the nucleus (Fig. 2-4E).  
 To examine the topographical organization of projections from the GPe to the STN, viral 
injections were targeted to rostral and caudal portions of the GPe (Fig. 2-4F). No differences in 
axonal projection patterns to the STN were observed in the Lhx6-Cre line from different regions 
of the GPe. In contrast, axonal projection patterns to the STN were topographically organized in 
the PV-Cre line. The rostral-ventral region projected to the central portion of the STN and rarely 
showed expression in the periphery (Fig 2-4G, left). In contrast, the caudal region of the GPe 
projected to the periphery of the STN, similar to what was observed in the Lhx6 population (Fig. 
2-4G, right). These results suggest a topographic organization of PV projections to distinct zones 
within the STN. 
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Figure 2-4 PV-GPe neurons project more strongly 
to the STN than Lhx6-GPe neurons.  
A. Schematic of central sagittal plane used for 
analysis. B. Normalized fluorescence intensity of 
axons from Lhx6- and PV-GPe neurons in the STN. 
Error bars are SEM. C. Fluorescence intensities 
measured in the GPe of Lhx6 and PV-Cre mice 2 
weeks after viral injections. Error bars are s.d. D. 
Scatter plot showing similar, linear relationship 
between pixel intensity and bouton number within a 
143 µm2 area of tissue, analyzed in brain areas 
receiving low, medium, and high densities of axonal 
innervation. E. EYFP fluorescence in Lhx6-Cre (left) 
and PV-Cre (right) mice, two weeks after viral 
injections. (top) 2.5x-epifluorscent images displaying 
typical expression in the GPe and STN. (bottom) 10x-
epifluorescent images from the central plane of 
analysis displaying fluorescence in the STN. F. 
Schematic of topographic organization of PV-GPe 
projections from rostral (striped) and caudal (solid) 
GPe to the STN. G. Representative examples of viral 
injections in the rostral (left) or caudal (right) GPe and 
their resulting projections onto the STN. 
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2.3.5 Lhx6- and PV-GPe Neurons Differentially Innervate the Substantia Nigra Pars 
Compacta but Similarly Innervate GABAergic Output Nuclei of the Basal Ganglia 
The substantia nigra is subdivided into two regions that subserve distinct purposes in basal 
ganglia function (Fig. 2-5A). The pars reticulata (SNr) is made up of GABAergic neurons that 
act as a major output of the basal ganglia. The pars compacta (SNc) is a region that lies dorsal to 
the SNr and contains a dense collection of dopaminergic neurons that innervate the striatum and 
many other structures (Bjorklund and Dunnett, 2007). GPe projections have been shown to 
innervate both the SNr and SNc in rats but these connections are still poorly understood (Paladini 
et al., 1999). In the SNr, there was no significant difference in density of axons arising from 
Lhx6- vs. PV-GPe neurons (Lhx6 = 15.3 ± 3.85 a.u., n= 4 vs. PV = 22.8 ± 14.7 a.u., n = 3; p = 
0.3) (Fig. 2-5B). Both populations of neurons projected to the SNr diffusely with no clear 
topographical organization (Fig. 2-5C, top & middle).  
 A markedly different scenario was observed in the SNc. As seen in Figure 5C, the 
distinct clustering of axons was observed in the dorsal region of the substantia nigra. To resolve 
the borders of the SNc and SNr, tissue was stained with antibodies against tyrosine hydroxylase 
(TH) to label dopamine neurons. Axonal projections to the SNc were more concentrated than 
those to the SNr, and the majority of SNc projections arose from Lhx6-GPe neurons (Lhx6 = 
41.0 ± 9.40 a.u., n = 4 vs. PV = 21.4 ± 6.05 a.u., n = 3; p = 0.03) (Fig. 2-5C).  
 The internal segment of the globus pallidus (GPi), one of the major output structures of 
the basal ganglia, is nested in the internal capsule fibers between the GPe and STN (Fig. 2-5D). 
Both Lhx6- and PV-GPe neurons projected to the GPi in equal amounts (Lhx6 = 37.5 ± 25.7 a.u., 
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n = 4 vs. PV = 45.8 ± 11.1 a.u., n = 4; p = 0.57) (Fig 2-5E). As expected, axonal projections from 
the both populations of GPe neurons formed basket synapses onto the neurons of the GPi (Fig. 2-
5F). Viral expression was not observed in GPi neurons. 
 
 
Figure 2-5 Lhx6- and PV-GPe projections to basal ganglia output nuclei.  
A. Schematic of central sagittal plane used for analysis and reference to the distinct areas of the susbtantia nigra: 
pars compacta (SNc, red) and pars reticulata (SNr, green). B. Normalized fluorescence intensity of axons from 
Lhx6- and PV-GPe neurons in the SNr and SNc. Lhx6-GPe neurons projected more densely to the SNc than PV-
GPe neurons and Lhx6 projections to the SNc were denser than those to the SNr. Error bars are SEM. C. (top) 
Epifluorescent images of axons from Lhx6- and PV-GPe neurons in the SNr and SNc (outlined with dotted line). 
(middle) Overlay of GPe axons (green) and TH immunofluorescence (red). (bottom) Confocal images of Lhx6- and 
PV-GPe axons (green) in the SNc; TH+ dopamine neurons are red. D. Schematic of GPi location within the internal 
capsule. E. Normalized fluorescence intensity of axons from Lhx6- and PV-GPe neurons in the GPi. Error bars are 
SEM. F. Confocal images of Lhx6- and PV-GPe axons in the GPi. Note the GPi neurons did not express EYFP. 
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2.3.6 Lhx6-GPe Neurons Project More Densely to the Dorsolateral Striatum than PV-
GPe Neurons 
The densities of axons from Lhx6- or PV-GPe neurons innervating the striatum were quantified 
within three functionally distinct striatal zones: dorsolateral, dorsomedial, and ventral. The 
dorsolateral region of the striatum is important for sensorimotor processing while ventral 
striatum deals with appetitive and rewarding aspects of behavior (Packard and Knowlton, 2002, 
Kelley, 2004, O'doherty et al., 2004). The dorsomedial region is important for instrumental 
conditioning and behavioral flexibility and is considered the associative territory of striatum 
(Ragozzino et al., 2002, Yin et al., 2005). GPe neurons sent sparse projections to striatum and 
formed a gradient of high to low density along the dorsal-ventral axis and the lateral-medial axis 
(Fig 2-6B-C).  
 In the dorsolateral region of the striatum, where GPe projections were most dense, axonal 
projections from Lhx6-GPe neurons were significantly more dense than axonal projections from 
PV-GPe neurons (DL StrLhx6 = 3.80 ± 1.38 a.u., n= 4 vs. DL StrPV = 1.14 ± 0.27 a.u., n = 4, p 
= 0.009) (Fig. 2-6B-C). In contrast, axonal projections to the medial striatum, an associative 
territory of the striatum, were less dense for both  cell-types and the density did not differ 
significantly between Lhx6- and PV-GPe neurons (DM StrLhx6 = 0.79 ± 1.32 a.u., n = 4 vs. DM 
StrPV = 0.32 ± 0.29 a.u., n = 4, p = 0.5) (Fig. 2-6B). Similarly, the ventral striatum showed little 
to no axonal projections from both populations of neurons (V StrLhx6 = 0.34 ± 0.23 a.u., n = 4; 
V StrPV = 0.19 ± 0.31 a.u., n = 4, p = 0.48).  
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Figure 2-6 Lhx6-GPe neurons project more strongly to the doroslateral striatum than PV-GPe neurons.  
A. Schematic of sagittal plane used for analysis. DL = dorsolateral striatum; V = ventral striatum. B. Normalized 
fluorescence intensity of axons from Lhx6- and PV-GPe neurons to the dorsolateral striatum (DL), dorsomedial 
striatum (DM), and ventral striatum (V). Striatal projections from both  cell-types were significantly denser to the 
dorosolateral region than to the dorsomedial or ventral regions (Lhx6: DL vs. DM, p = 0.020; DL vs. V, p = 0.003; 
PV: DL vs DM p = 0.006; DL vs V, p = 0.004); dorosolateral projections from Lhx6-GPe neurons were significantly 
denser than dorosolateral projections from PV-GPe neurons. Error bars are SEM. C. Epifluorescent images of axons 
from Lhx6- and PV-GPe neurons in the striatum. D. Confocal images showing the selective innervation of Lhx6-
GPe axons (top, green) or PV-GPe axons (bottom, green) onto striatal FSIs (red). E. Results of Sholl analysis. 
Number of boutons from Lhx6-GPe (top) or PV-GPe (bottom) neurons were counted in concentric circles of 
increasing diameter (2 µm) around striatal FSIs or MSNs. F. Bar graphs comparing total number of boutons onto 
FSIs or MSNs from Lhx6-GPe (top) or PV-GPe (bottom) neurons. G. Bar graph showing the percentage of Fluoro-
Gold-labeled neurons that were either Lhx6+ or PV+. Significantly more Fluoro-Gold neurons were Lhx6+ than 
were PV+. H. Confocal images of the GPe in tissue from an Lhx6-GFP mouse, stained for PV and antibodies against 
Fluoro-Gold. The Lhx6- (Left) and PV-GPe (Right) neurons (green) showed colocalization with the retrograde 
tracer, FG (red). Arrows indicate double labeled neurons. 
 
 Consistent with previous work, axonal projections from both Lhx6- and PV-GPe neurons 
appeared to target GABAergic interneurons in the striatum (Bevan et al., 1998), as indicated by 
axonal varicosities which were clustered around PV+ interneurons, corresponding to fast-spiking 
interneurons (FSIs) (Fig. 2-6D). To quantify the selectivity of GPe innervation for striatal FSIs 
compared to MSNs, we counted the number of boutons surrounding each  cell-type using a Sholl 
analysis (Chattopadhyaya et al., 2004). Striatal FSIs received significantly more innervation from 
the GPe than MSNs (Fig. 2-6E-F).  
 Our quantification of axon densities suggest that Lhx6-GPe neurons give rise to a greater 
proportion of striatal projections than do PV-GPe neurons. To confirm this result, we injected the 
retrograde tracer, Fluoro-Gold, into the dorsolateral striatum of Lhx6-GFP or PV-Cre x Ai9 mice 
(Fig. 2-6G-H). After two weeks, tissue was processed and analyzed to determine what 
percentage of retrogradely-labeled neurons in the GPe were either Lhx6 or PV. As shown in Fig. 
2-6G, Fluoro-Gold labeled significantly more Lhx6-GPe neurons than PV-GPe neurons (Lhx6 = 
47.5 ± 18.4%, n = 84/177 vs. PV = 30.5 ± 11.0%, n = 59/182; p = 0.003, Fisher's Exact Test). 
Together, these data suggest that a greater proportion of GPe projections to the striatum arise 
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form Lhx6-GPe neurons and the focus of these projections is interneurons in the sensorimotor 
input region of the striatum. 
2.3.7 Distinct Projections of PV-GPe Neurons to the Parafascicular Nucleus of the 
Thalamus 
GPe projections to the thalamus have been previously described (Hazrati and Parent, 1991, 
Chattopadhyaya et al., 2004), but are typically restricted to reticular nucleus of the thalamus, 
which is located rostral to the GPe and extends further medially in the brain (Fig. 2-7A). The 
reticular nucleus is a specialized thalamic nucleus containing mostly GABAergic neurons that 
inhibit numerous thalamic nuclei and have no direct cortical projections (Houser et al., 1980, 
Ohara, 1988, Pinault and Deschenes, 1998). Consistent with previous studies, axonal projections 
from both populations of neurons were found in the reticular nucleus with no significant 
difference in density (Lhx6 = 28.0 ± 6.71 a.u., n = 4 vs. PV = 24.4 ± 14.0 a.u., n = 4; p = 0.6) 
(Fig. 2-7B-C).  
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Figure 2-7 Lhx6- and PV-GPe projections to the thalamus.  
A. Schematic of thalamic nuclei locations in a medial sagittal slice. RT = reticular nucleus; pf = parafasicular 
nucleus.  B. Normalized fluorescence intensity of axons from Lhx6- and PV-GPe neurons to the RT. There was no 
significant difference between the two populations. Error bars are SEM. C. Epifluorescent images of axons from 
Lhx6- and PV-GPe neurons in the RT. D. Normalized fluorescence intensity of axons from Lhx6- and PV-GPe 
neurons in the pf. Axons from Lhx6-GPe neurons were not observed in the pf. Error bars are SEM. E. Epiflourescent 
images of axons from Lhx6- and PV-GPe neurons in the pf. (inset) Confocal image of dense axonal innervation in 
the pf from PV-GPe neurons. Scale bar, 25 µm. F. IPSC recorded in a pf neuron in response to optical stimulation (1 
ms) of ChR2-expressing PV-GPe axons. Graph shows IPSC amplitudes recorded from five pf neurons and the 
population average. 
 
 In contrast to projections to the reticular nucleus, Lhx6-and PV-GPe neurons differed 
substantially in their projections to the parafascicular nucleus. The Lhx6-GPe population 
exhibited virtually no axonal projections to the parafascicular nucleus while PV-GPe neurons 
projected densely, covering the full extent of nucleus (Lhx6 = 0.83 ± 1.3 a.u., n = 4 vs. PV = 
69.0 ± 19.9 a.u., n = 4; p = 0.0005) (Fig 7D-E). As seen in Figure 7E, the nuclei surrounding the 
parafascicular nucleus showed no axonal projections, which would be expected if axons arose 
from spillover labeling of neurons in the reticular nucleus. Furthermore, there was a topographic 
organization of projections from the GPe to the parafascicular nucleus. Upon targeted injections 
of rostral and caudal portions of the GPe, we found that the parafascicular nucleus was only 
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targeted by caudal PV-GPe neurons but not by rostral PV-GPe neurons (data not shown). 
Injections in the rostral portion of the GPe show little to no expression within the parafascicular 
nucleus. To ensure that PV-GPe axonal projections to the parafascicular nucleus were 
functionally active and not just fibers of passage, a virus containing ChR2-EYFP was injected 
into the GPe of PV-Cre mice. Optically evoked inhibitory synaptic currents (IPSCs) from a 
holding potential of -70 mV were observed in 5/5 pf neurons (565.04 ± 312.3 pA, n = 5) (Fig. 2-
7F), confirming that PV-GPe neurons form functional inhibitory synapses onto parafascicular 
nucleus neurons. These results suggest the presence of a previously undescribed output 
projection from the GPe to the parafascicular nucleus. 
2.4 DISCUSSION 
Here, we establish the use of Lhx6 and PV transgenic mouse lines to identify genetically distinct 
classes of GPe neurons that differ molecularly, anatomically, and electrophysiologically. Viral-
mediated expression of EYFP revealed that both Lhx6- and PV-GPe neurons differed in their 
axonal innervation of a number of brain regions, including the striatum, SNc, STN, and the 
parafascicular nucleus. These results reveal cell-type specific segregation of GPe output and 
establish genetic tools for elucidating the role of distinct GPe output pathways in behavior and 
disease. 
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2.4.1 Lhx6 and PV Transgenic Mouse Lines Subdivide GPe Neurons Into Two Groups 
Approximately two-thirds of GPe neurons were labeled in Lhx6 (1/3) or PV (1/3) transgenic 
mouse lines. The remaining 1/3 of GPe neurons could represent a third, as yet unidentified 
neuronal population in the GPe, or could represent incomplete labeling of Lhx6 and PV 
populations. Although the fraction of PV-GPe neurons in mice (1/3) was lower than that reported 
in rats (2/3) (Kita, 2007), we observed a similarly low number of PV neurons using both 
immunohistochemical and genetic techniques. These results suggest that the number of PV-GPe 
neurons is lower in mice than in other species such as rats and primates.  
 Lhx6 is a homeobox protein expressed in the medial ganglionic eminence (MGE) during 
development. The MGE is the origin of most forebrain GABAergic interneurons (Marin et al., 
2000, Cobos et al., 2006) as well as GPe neurons (Flandin et al., 2010, Nobrega-Pereira et al., 
2010). It remains unclear why only a subset of GPe neurons are labeled in Lhx6 transgenic mice, 
but one possibility is that Lhx6-GPe neurons correspond to a fraction of MGE neurons in which 
Nkx2.1 expression is downregulated during embryonic stages (Nobrega-Pereira et al., 2010). 
Whereas PV has been previously used to identify a subset of GPe neurons (Kita, 1994, Kita, 
2007, Mallet et al., 2012), our results show for the first time that Lhx6 can be used to identify a 
second, non-overlapping subset of GPe neurons.   
 Lhx6- and PV-GPe neurons were differentially distributed along the lateral-medial axis 
of the GPe. PV-GPe neurons were more densely distributed in the lateral portion of the GPe, the 
sensorimotor territory of the nucleus (Alexander and Crutcher, 1990, Matsumura et al., 1995, 
Haber et al., 2000, Francois et al., 2004), where pharmacological activation produces dyskinetic 
movements in primates (Matsumura et al., 1995, Grabli et al., 2004). In contrast, Lhx6-GPe 
neurons, were more densely distributed in the medial portion of the GPe, the limbic and 
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associative territories of the nucleus (Alexander and Crutcher, 1990, Haber et al., 2000, Francois 
et al., 2004), where pharmacological activation produces stereotypies and hyperactivity (Grabli 
et al., 2004). 
2.4.2 Lhx6 and PV Neurons Have Different Intrinsic Electrophysiological Properties 
Differences in the electrophysiological properties of GPe neurons have been described both in 
vivo (Kelland et al., 1995, Mallet et al., 2008, Benhamou et al., 2012, Mallet et al., 2012) and in 
slice preparations (Nambu and Llinas, 1994, Cooper and Stanford, 2000, Kita, 2007, Deister et 
al., 2013), but a rigorous classification scheme has not been established. Furthermore, there is 
some controversy about whether or not intrinsic properties can even be used to define groups of 
GPe neurons because these properties vary continuously across the population and can change 
during the course of an experiment (Gunay et al., 2008, Deister et al., 2013).  
 Because Lhx6- and PV-GPe neurons are genetically defined, this establishes a rigorous 
classification scheme with which to determine how intrinsic firing properties vary across  cell-
types in the GPe. Intracellular recordings from Lhx6- and PV-GPe neurons revealed that intrinsic 
parameters varied continuously across the population, but a number of parameters differed 
significantly between these two  cell-types. PV-GPe neurons had narrower action potentials and 
could sustain higher maximum firing rates than Lhx6-GPe neurons, suggesting PV-GPe neurons 
are better tuned to reliably respond to rapid, high frequency inputs than Lhx6-GPe neurons. In 
addition, PV-GPe neurons had lower input resistances and higher whole cell capacitances than 
Lhx6-GPe neurons, suggesting that PV-GPe neurons are larger.  
 Lhx6- and PV-GPe neurons also differed with respect to spontaneous firing rates, which 
were higher in PV-GPe neurons. Spontaneous firing in GPe neurons is mediated by a 
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combination of Ih and persistent Na+ currents (Chan et al., 2004, Mercer et al., 2007, Chan et al., 
2011). Our results that sag currents were similar between Lhx6- and PV-GPe neurons suggests 
that additional currents besides Ih may contribute to the different firing rates between these two 
cell populations, including persistent Na+ currents, or Ca2+-sensitive K+ currents which have 
also been shown to regulate firing rates in GPe neurons (Deister et al., 2009, Schultheiss et al., 
2010). 
2.4.3 Implications of Genetically-Defined Output Pathways for Basal Ganglia Function 
Historically, one of the most robust classification schemes for GPe neurons has been based on 
their axonal projection patterns (Bevan et al., 1998, Hoover and Marshall, 1999, Kita et al., 1999, 
Sato et al., 2000, Hoover and Marshall, 2002, Kita, 2007, Mallet et al., 2012). Although both 
Lhx6- and PV-GPe neurons projected to many of the same brain regions, the density of these 
projections differed significantly in a number of areas, including the striatum and SNc, which 
were more densely innervated by Lhx6-GPe neurons, and the STN and parafasicular nucleus, 
which were more densely innervated by PV-GPe neurons (Fig. 2-8). Both  cell-types made 
similarly dense projections to a number of additional brain regions, both within and outside the 
basal ganglia, including the GPi, SNr, reticular nucleus of the thalamus, basolateral amygdala, 
and parasubthalamic nucleus (Fig. 2-8). We also observed that both  cell-types made projections 
to the cortex, but the diffuse nature of these projections made quantification difficult. 
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Figure 2-8 Summary of cell-type specific projection densities 
Summary of normalized fluorescence intensity of axons from Lhx6- (white) and PV-GPe (black) neurons to 
identified brain structures. Error bars are SEM. Asterisks denote significance between  cell-types. 
 
 Based on axonal density and retrograde labeling, we found that Lhx6-GPe neurons made 
up a greater portion of GPe projections to the striatum than PV-GPe neurons. This is consistent 
with previous studies in which most striatal-projecting neurons lack PV expression (Hoover and 
Marshall, 1999, Kita et al., 1999, Hoover and Marshall, 2002, Mallet et al., 2012). Our results 
suggests that Lhx6 labels a greater proportion of ‘pallidostriatal neurons’ previously described in 
monkeys and rats (Bevan et al., 1998, Sato et al., 2000). Axons of pallidostriatal neurons target 
GABAergic interneurons in the striatum (Bevan et al., 1998), and this projection may play an 
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important and underappreciated role in regulating striatal activity (Wilson, 2009, Gage et al., 
2010).  
 Lhx6-GPe neurons also make stronger projections to the SNc than PV-GPe neurons. The 
SNc contains the majority of dopamine neurons that innervate the dorsal striatum as well as the 
GPe (Parent and Smith, 1987, Lavoie et al., 1989, Rommelfanger and Wichmann, 2010). 
Dopamine release from the SNc is critically involved in motor aspects of basal ganglia function 
(Gerfen et al., 1990, Bjorklund and Dunnett, 2007, Kreitzer and Malenka, 2008, Gerfen and 
Surmeier, 2011, Surmeier et al., 2011), therefore, projections from Lhx6-GPe neurons may play 
an underappreciated yet influential role in movement (Hausser and Yung, 1994, Paladini et al., 
1999).  
 The axonal projections of PV-GPe neurons were significantly stronger to the STN than 
those of Lhx6-GPe neurons. The difference in STN innervation by PV- and Lhx6-GPe neurons 
was most apparent in an inner region of the nucleus, largely devoid of innervation from Lhx6-
GPe neurons but strongly innervated by PV-GPe neurons located in the rostral portion of the 
nucleus. This result confirms the presence of a topographical projection from the GPe to the STN 
that has been observed in primates (Francois et al., 2004), but the functional role of the medial 
portions of the STN in rodents is not known. The GPe and STN form a reciprocally connected 
network that has received much attention for its role in pathological oscillations in Parkinson’s 
disease (Bergman et al., 1994, Nini et al., 1995, Plenz and Kital, 1999, Magill et al., 2001, Bevan 
et al., 2002, Terman et al., 2002, Mallet et al., 2008, Holgado et al., 2010, Fan et al., 2012). 
Although both Lhx6- and PV-GPe neurons project strongly to the STN, changes in the denser 
PV-GPe projections may play a more prominent role in the development or maintenance of 
pathological oscillations in Parkinson’s disease.  
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 The most striking difference in the projection patterns of Lhx6- and PV-GPe neurons 
observed was in the parafascicular nucleus, which received dense innervation from PV-GPe 
neurons but not Lhx6-GPe neurons. The parafascicular nucleus plays a role in attention and 
behavioral flexibility and its projections to the striatum are particularly important for the control 
of cholinergic interneurons (Matsumoto et al., 2001, Minamimoto and Kimura, 2002, Smith et 
al., 2004, Smith et al., 2011). The dense projections of PV-GPe neurons to the parafascicular 
nucleus suggest that they are an important component of non-motor output pathways of the GPe. 
The parafascicular nucleus may play a role in motor control as well, based on results that deep 
brain stimulation in the parafascicular nucleus is particularly effective at alleviating tremors in 
patients with movement disorders (Krauss et al., 2002, Goff et al., 2009, Stefani et al., 2009). 
 In summary, we have shown that Lhx6 and PV transgenic mice can be used as tools to 
identify genetically-distinct circuits within the GPe with the potential to subserve different roles 
in basal ganglia function. By virtue of their projections to striatal interneurons and SNc 
dopamine neurons, Lhx6-GPe neurons are well positioned to regulate striatal output and 
influence the balance of direct and indirect pathway activity to determine overall levels of motor 
output. In contrast, PV-GPe neurons make stronger projections to the STN and parafascicular 
nucleus, brain areas with both motor and non-motor functions, and areas that have been 
implicated specifically in the generation of pathological oscillations and tremor in Parkinson’s 
disease, suggesting a role of PV-GPe neurons in these aspects of disease pathophysiology. 
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3.0  CELL-TYPE SPECIFIC PALLIDAL INTERVENTION INDUCES LONG-
LASTING MOTOR RECOVERY IN DOPAMINE-DEPLETED MICE  
The identification of distinct cell-types within the basal ganglia has played a critical role in our 
understanding of basal ganglia function and the treatment of neurological disorders. The external 
globus pallidus (GPe) is a key contributor to motor suppressing pathways in the basal ganglia, 
yet its neuronal heterogeneity has remained an untapped resource for therapeutic interventions. 
Here, we demonstrate that optogenetic interventions that dissociate the activity of two neuronal 
populations in the GPe – elevating the activity of PV-GPe neurons over that of Lhx6-GPe 
neurons – restores movement in dopamine depleted mice and attenuates pathological activity of 
basal ganglia output neurons for hours beyond stimulation. These results establish the utility of 
cell-specific interventions in the GPe to target functionally distinct pathways, with the potential 
to induce long-lasting recovery of movement despite the continued absence of dopamine. 
3.1 INTRODUCTION 
Cell-types in neural circuits provide a functional diversity that can be harnessed to treat 
neurological disorders. The identification of distinct cell-types within the basal ganglia has 
played a critical role in our understanding of basal ganglia function and the treatment of 
neurological disorders, particularly Parkinson’s disease (PD). However, a major limitation of PD 
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treatments is that they provide only transient relief of symptoms, which rapidly return if a drug 
dose is missed or deep brain stimulation (DBS) is discontinued.  
The external globus pallidus (GPe) is a key contributor to motor suppressing pathways in 
the basal ganglia, yet its neuronal heterogeneity has remained an untapped resource for 
therapeutic interventions. It extends projections to all nuclei within the basal ganglia as well as 
the thalamus, amygdala, brainstem, and cortex(Kita, 2007, Mastro et al., 2014, Saunders et al., 
2015), and has been implicated as a critical node in the generation and amplification of 
pathological activity in the dopamine depleted (DD) state(Bergman et al., 1998, Bevan et al., 
2002, Mallet et al., 2008). Recently, molecular and genetic strategies have been developed to 
subdivide GPe neurons into different subpopulations that vary in physiological and anatomical 
projections(Mallet et al., 2012, Mastro et al., 2014, Abdi et al., 2015, Dodson et al., 2015, 
Hernandez et al., 2015, Saunders et al., 2015). Two major subdivisions are ‘prototypical’ and 
‘arkypallidal’ neurons(Mallet et al., 2012, Dodson et al., 2015, Hegeman et al., 2016). 
Approximately 75-80% of GPe neurons are prototypical, meaning they have high, regular firing 
rates in vivo and project strongly to downstream basal ganglia nuclei(Dodson et al., 2015, 
Hernandez et al., 2015). Within the prototypical population, neurons can be further subidivded 
based on expression of parvalbumin (PV-GPe) and lim homeobox 6 (Lhx6-GPe)(Mastro et al., 
2014, Oh et al., 2016b). Although expression of these markers is partially overlapping(Abdi et 
al., 2015, Dodson et al., 2015, Hernandez et al., 2015, Oh et al., 2016b), as a whole, PV and 
Lhx6 populations differ in their intrinsic physiology and projection densities to downstream 
nuclei(Mastro et al., 2014). To date, however, the behavioral significance of these neuronal 
subdivisions has not been directly demonstrated.   
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Here, we demonstrate that in DD mice, transiently dissociating the activity of PV-GPe 
and Lhx6-GPe subpopulations induces long-lasting recovery of movement and reversal of 
pathological activity in the basal ganglia circuit that persists for hours beyond stimulation. These 
prokinetic effects are only engaged by restricting manipulations to particular neuronal subsets, 
and not by manipulations that modulate all GPe neurons simultaneously. These results establish 
the behavioral relevance of functionally distinct neuronal subpopulations in the GPe and suggests 
their potential as therapeutic nodes for the long-term restoration of movement in PD. 
3.2 MATERIALS AND METHODS 
3.2.1 Animals 
Experimental procedures were approved by the Carnegie Mellon University Committee for the 
Use and Care of Animals and in accordance to the guidelines set forth by the National Institute 
of Health and Society for Neuroscience Use of Animals in Neuroscience Research. Male and 
female heterozygous 8-15 week-old mice on a C57BL/6J background were used for all 
experiments. D1-SPNs were targeted using the D1-cre mouse line(Gong et al., 2007). PV-GPe 
neurons were targeted using a Pvalb-2A-Cre mouse line(Madisen et al., 2010). Lhx6-GPe 
neurons were targeted using Lhx6-iCre mouse line(Fogarty et al., 2007). To ensure health of the 
animals undergoing the dopamine depletion, weights were closely monitored and every animal 
weighed greater than 20 g prior to initial surgery. Animals were group housed (2-8 per group) in 
a 12hr-12hr light dark cycle until the time of second surgery (as noted below) and all 
experiments were completed during the light cycle. 
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3.2.2 Viral Transfection 
Injections of purified double-floxed AAV2-DIO-EYFP (controls), AAV2-DIO-ChR2-EYFP 
(cell-specific activation), AAV2-DIO-ArChT-tdTomato (cell-specific inhibition), AAV2-hsyn-
hChR2(H132R)-tdTomato (non-specific activation) or AAV2-CAG-ArchT-tdTomato (non-
specific inhibition) produced at the University of North Carolina (Vector Core Facility) were 
made in 8-12 week-old D1-cre, PV-Cre or Lhx6-iCre transgenic mice. Littermates were 
randomly assigned to either the rhodopsin-positive or control groups. Injections into the 
dorsomedial striatum(Kravitz et al., 2010) or GPe(Mastro et al., 2014) were completed in 
accordance to methods previously described. Briefly, anesthesia was induced using 0.2 µL 
ketamine/xylazine (0.2cc/ 5 mg/ml) and maintained throughout surgery using 1.5% isofluorane. 
Mice were placed in a stereotaxic frame (Kopf Instruments) where the scalp was opened and 
bilateral holes were drilled in the skull (Striatum: 0.5mm anterior, 1.5mm lateral, GPe: 0.27-0.30 
mm anterior, 2.1-2.2 mm lateral from bregma). 200–250 nL of virus was injected with a 
Nanoject (Drummond Scientific) through a pulled glass pipet (tip diameter ~30 µm) whose tip 
was positioned below the top of the skull (Striatum: 2.80 mm, GPe: 3.65 mm).  To prevent 
backflow of virus, the pipet was left in the brain for 5 min after completion of the injection. All 
experiments were performed at least 2 weeks following injection to allow time for full viral 
expression. At which point, mice underwent a second surgery for either behavioral optogenetics 
or physiology, where experimenters were blind to the experimental condition. Sample sizes for 
each experiment are in line with previous published studies(Gradinaru et al., 2009, Kravitz et al., 
2010). 
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3.2.3 Optogenetic Behavioral Implantation and Dopamine Depletion 
For behavioral optogenetic experiments in freely moving mice, a second surgery was performed 
at least 10 days after viral injections to deplete dopamine and insert optical fibers. For the second 
surgery, mice were anesthetized, placed on the stereotaxic frame and holes were re-drilled from 
the previous viral injection. In addition, bilateral holes were drilled over the medial forebrain 
bundle (-0.45 mm posterior, +/-1.15 mm lateral from bregma) for 6-OHDA injections. A 33-
gauge cannula (Plastics One, Roanoke, VA, USA) attached to a syringe pump, was slowly 
lowered down into place (MFB: 4.95mm from top of the skull) and allowed to settle for five 
minutes. At this point, 1 µL of 6-OHDA (5 μg/μL in 0.9% NaCl), saline (0.9% NaCl) for 
unilateral depletions or lipopolysachairide (LPS, Sigma-Aldrich) for inflammatory induction was 
slowly injected into the MFB at a rate of 0.1 µL/min. The injection cannula was left in place for 
five additional minutes. 
 After the bilateral injections, a custom-made plastic button containing 2 polished ferrules 
was placed over the holes previously used for viral injections. The fibers were slowly advanced 
to the top of the viral expression (Striatum: 2.60 mm, GPe: 3.45 mm). Dental cement was used to 
secure the button to the top of the skull. After all dopamine depletions, mice were individually 
housed and placed into a recovery station. The station consisted of a new cage, soft food, trail 
mix, shallow water dish and half of the cage was placed on a heating pad. In addition, a daily 
injection of saline (0.9% NaCl; intraperitoneally) was used to curb dehydration, and weight was 
closely monitored to ensure the greatest level of health for each animal. 
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3.2.4 Behavioral Paradigm 
Three to five days following fiber implantation, mice were connected to bilateral fibers and 
subsequently placed in the center of a 1600 cm2 square open field. Fibers were adjusted to 
ensure 1 mW of power at the tip of the previously implanted ferrule. Activity was monitored 
from overhead and the side of the arena and the center-point was tracked utilizing Noldus 
Ethovision software. After collecting 10 minutes of ‘baseline’ activity, the LED delivered a 30 
second pulse of light that was repeated 10 times and separated by 3 minute intervals. Following 
the final stimulation bout, 10 minutes of ‘post-stim’ activity was collecting. In a subset of 
conditions, mice were observed for an additional three hours to capture the persistence of 
behavioral intervention.  
 For the food-retrieval task, mice were placed in a new cage (30 x 20 cm) following the 
completion of the behavioral paradigm. Mice were placed in the opposing corner of the cage 
from two small dishes of food and water. Mice were tracked overhead using Noldus Ethovision. 
Successful trials were when mice reached the food or water dishes within 5 min. 
3.2.5 Implantation of Head-Fixation System 
A subset of virally injected mice were utilized for head-fixed in vivo physiology. Two weeks 
following viral expression, mice followed the same dopamine depletion protocol described 
above. After the bilateral injection of 6-OHDA, bilateral craniotomies were created over the GPe 
(-0.45-0.45 mm anterior, 1.75-2.35 mm lateral to bregma) or SNr (-2.75-3.25 mm anterior, 1.15-
2.00 mm lateral to bregma). For SNr recordings, holes were drilled over the site of viral 
injections into the GPe and fibers (transmittanceoutput = 1 mW measured at the end of the fiber) 
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were implanted for direct optical stimulation during recordings. After which, all animals were 
implanted with a copper headpost fixed to the posterior portion of the skull (approximately -3.5 
mm posterior to bregma) utilizing a combination of glue and dental cement. The dental cement 
fixation was extended to surround the entirety of both craniotomies. The subsequent well that 
was formed was filled with a silicon elastomer (Kwik-sil, WPI) that prevented infection and 
damage to the brain tissue. During recording, this well was filled with saline and used as a 
ground reference. 
3.2.6 Head-Fixation Training and Recording 
Mice were placed atop a running wheel and allowed to run freely for 60 minutes the day before 
recording. Movement was tracked for the full period of recordings using an inverted optical 
mouse and custom MATLAB script. Craniotomies were cleaned, prepared for recordings the 
following day and silicone elastomer was replaced. 
GPe Recordings: On the day of recording, mice were fixed to the top of the wheel and allowed 
15 minutes to acclimate to the head fixed position. After removal of the silicon elastomer and 
clearing of the craniotomy, a linear 16-channel silicone optrode with sites spaced 50 µm apart 
(Neuronexus) and a 100 µm fiber terminating 50 µm above the uppermost site was attached to 
the micromanipulator and centered on bregma. Transmittance through the optical fiber was 
measured prior to recording to ensure ~0.5 mW in both the blue and green light conditions. The 
probe was slowly advanced (5-7 µm/sec) until the top of the GPe (~3.20 mm from top of the 
skull) was found. GPe activity was distinguished based on a combination of physiological 
features: presence of high-firing neurons, presence of low firing, irregular neurons, lack of 
spindle-like activity (thalamic) and responsiveness to light activation or inhibition. Post-mortem 
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tissue analysis for viral hit and craniotomy placements were further evidence for proper 
targeting. 
The probe was left in place for approximately 15 min before neuronal activity was 
measured. During this time, a drop of saline was placed in the well that surrounds the craniotomy 
and a reference ground electrode was placed in contact with the saline. Extracellular recordings 
and local field potentials were acquired using the omniplex system (Plexon Inc) and stored for 
offline analysis. 
3.2.7 Optical Tagging Method 
In the cell-type manipulations, single units could be isolated and an optical tagging strategy was 
employed to distinguish a neuron’s activity as positive or negative for rhodopsin expression. For 
ChR2 conditions, brief pulses (pulse width = 5 ms, 10 Hz, 120 pulses) were administered at the 
start and end of each recording session before advancing the probe to the next location. For Arch 
conditions, a set of longer pulses (pulse width = 1 sec, 0.5 Hz, 10-20 pulses) was administered to 
clearly denote neurons that were directly inhibited by the light. After the optical tag, activity of 
the neurons was measured in response to a thirty second period of light. In a subset of neurons, 
stability of recording was great enough to allow for the application of the full optogenetic 
paradigm (pulse width = 30 sec, interpulse interval = 3 min, 10 pulses). After the recording 
period, mice were sacrificed and tissue was utilized to verify placement of the craniotomy and 
documentation of probe entrance and placement. 
 For analysis, we utilized the previously published identification tool to classify neurons 
based on responsiveness to brief pulses (5 ms)(Kravitz et al., 2013). Briefly, baseline activity (-
110 to -10 ms) for each pulse was compared to the number of significant bins within 0-10 ms of 
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light onset. As seen in Fig. A5a, the first significant bin (yellow) denotes the latency to spike due 
to direct ChR2-activation. For the Arch tagging, peri-event histograms (bin size = 10 - 50 ms) 
were produced centered on the start of each of the 10-20 pulses and a student’s t test (p < 0.005) 
was performed to compare the baseline firing rate (-510 ms to -10 ms from light onset) to the 
firing rate during light onset (0 ms to 200 ms). 30 sec Pulse Analysis: Neurons were binned 
based on the average firing rate changes during stimulation compared to 20 seconds prior to 
stimulation. 
3.2.8 SNr Recordings 
Following the acclimation protocol described earlier, mice were fixed atop the wheel and the 
appropriate light source was attached to the optical fibers (transmittance = 1 mW, tested prior to 
implantation). After removal of the silicon elastomer and clearing of the craniotomy, a linear 16-
channel silicone probe with sites spaced 50 µm apart (Neuronexus) was centered on lambda. The 
probe was slowly advanced (5-7 um/sec) until the top of the SNr (~4.75 mm from top of the 
skull) was found. SNr activity was distinguished based on a combination of physiological 
features: presence of putative dopamine neurons, presence of putative GABAergic neurons, lack 
of spindle-like activity (thalamic) and responsiveness to light activation or inhibition. Post-
mortem tissue analysis for viral hit and craniotomy placements were further evidence for proper 
targeting. 
During the pre- and post-stimulation period, the probe was advanced to record a new set 
of neurons every 30-40 mins. Due to the scale of our craniotomy, when the probe was advanced 
to the bottom of the SNr (~5.00 mm), the probe was taken out of the brain and reinserted. This 
allowed for sampling across the SNr. During the full optical stimulation, the probe was left at the 
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same recording site for the full duration, including an additional 10 minutes before and after 
stimulation. In a subset of the recordings, the signal to noise ratio and the subsequent population 
clusters were sufficiently isolated to track a set of neurons throughout the recording. 
3.2.9 Tissue Processing 
Shortly after the behavioral or electrophysiology experiments, mice were sacrificed and perfused 
transcardially with phosphate buffered saline (PBS), followed by 4% paraformaldehyde (PFA) in 
PBS. Brains were retrieved, fixed in 4% PFA for 24 hr before being placed in a 30% sucrose 
solution. Brains were sliced at 30 µm thickness and prepared for the appropriate incubations, as 
described previously50. Primary antibody included rabbit anti-GFP (1:1000, Millipore 06-896), 
Mouse anti-HuC/D (1:200, Molecular Probes A21271), mouse anti-NeuN (1:100, Millipore 
MAB377), rabbit anti-TH (1:1000, Pel-Freez P40101-0), at room temperature for 24 hours or at 
4°C for 48 h when using rabbit anti-PV (1:1000, Swant PV 27). Secondary antibodies included 
Alexa Fluor 488-conjugated goat anti-chicken (1:500, Life Technologies), Alexa Fluor 488-
conjugated goat anti-rabbit (1:500, Life Technologies), Alexa Fluor 568-conjugated donkey anti- 
rabbit (1:500, Life Technologies), Alexa Fluor 568-conjugated donkey anti-mouse (1:500, Life 
Technologies), Alexa Fluor 647-conjugated donkey anti-rabbit (1:500, Life Technologies), or 
Alexa Fluor 647-conjugated donkey anti-mouse (1:500, Life Technologies). 
3.2.10 TH Quantification 
Quantification of tyrosine hydroxylase staining was used as a measure of dopamine lesion on 
both hemispheres. As described previously50, slices containing the dorsal striatum were imaged 
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using an epifluorescent scope at 10x magnification. To analyze the fluorescent intensity, the 
pixel intensity-measuring tool in ImageJ was used. A 100 x 100 µm square from each 
hemisphere was measured and normalized to the pixel intensities of a healthy control tissue that 
was processed and imaged in parallel. Unless noted, all mice had <20% TH remaining on both 
sides for all behavioral and physiology experiments to limit behavioral variability. 
3.2.11 Behavioral Analysis 
Videos collected during the behavioral paradigm were analyzed using the Noldus Ethovision. 
Immobility was quantified as the period of time where there was less than 1.2% change in pixels 
corresponding to the body segment. Center point detection was utilized to calculate movement 
velocities during movement bouts (velocity > 1 cm/s for at least 1 sec). For quantification of 
behavioral patterns, the behavior of a subset of randomly selected animals in the dopamine intact 
control, PV-ChR2, and Lhx6-Arch conditions was manually scored using Observer software to 
denote start and stop times that mice engaged in walking, rearing, grooming, and fine 
movements (scratching, sniffing, looking around). Periods of time not engaged in any of these 
movements were classified as ‘immobile’ in behavioral pattern analyses. 
3.2.12 Electrophysiology Analysis 
Data was filtered at 150-8000 Hz for spiking activity and 0.7-300 Hz for local field potentials. 
Spike detection was completed using the Plexon offline sorter where principal component 
analysis was used to delineate single and multi-units. To be classified as a single unit, the 
following criteria was utilized: (a) PCA clusters were significantly different (p <0.001); (b) J3-
 60 
statistic was greater than 1; (c) percent of ISI violations (< 2ms) was less than 0.15%; (d) Davies-
Bouldin test statistic was less than 0.5; (e) manual verification that optical stimulation did not 
occlude the ability to delineate single units from noise.  
Following spike sorting, data was processed in Neuroexplorer and with custom scripts in 
MATLAB. Rest Period Analysis: Periods of rest were analyzed to identify the firing rates (FR) 
and coefficient of variation of the interspike intervals (CVISI) in the naive vs dopamine depleted 
state (Fig. A1c-e). Burst Analysis: Utilizing the surprise algorithm (surprise = 2), bursts were 
identified in the single unit SNr activity (FR > 5 Hz) and calculated across a two minute period, 
referred to as number of bursts (Fig. 3-6). For Fig. 3-6k-l, the number of bursts were calculated 
for thirty second time bins. Each unit was then normalized to baseline (Pre) and then averaged 
across all stably recorded units. Fractional Analysis: The fraction of highly ‘bursty’ neurons were 
identified by calculating the number of units that exceeded 1 MAD of the median in the 
distribution across all conditions, prior to optogenetic manipulation (Bursty threshold: 70). 
3.2.13 Statistics 
Statistical analysis were completed using SPSS software or GraphPad Prism 7 (GraphPad 
Software). All data was tested for normality and equal variance. Behavioral data were analyzed 
using two-sided, paired or unpaired Student’s t-tests for normally distributed data. In all other 
cases, a Mann Whitney U or a Chi-squared test was applied. For the analysis of behavioral 
persistence, behavioral conditions were tested using two-way repeated measures (RM) ANOVA 
and reported in the appropriate figure legend. As noted in the main text, comparisons made 
within or across conditions utilizied Tukey’s or Sidak post hoc test, respectively. Results are 
reported as mean ± S.D. 
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Physiology data was first tested for normality and equal variance. Then, the appropriate 
parametric (two sided, paired or unpaired Student’s t-test) or non-parametric (Mann Whitney U 
or Kruskal-Wallis H test) tests were applied. Cumulative distributions were compared using the 
Kolmogorov-Smirnov two sample test (K-S two sample test). Fractional burst analysis applied a 
chi-squared statistic to measure if there was a change in the population burst firing before and 
after optogenetic intervention. Physiology results were reported as mean ± SEM. The data that 
support the findings of this study are available from the corresponding author upon reasonable 
request. 
3.3 RESULTS 
3.3.1 Global GPe Stimulation Does Not Restore Movement in DD Mice 
A prediction of the classic model of basal ganglia function under dopamine depleted (DD) 
conditions is that increasing firing rates of GPe neurons should improve movement(Albin et al., 
1989, DeLong, 1990). To test this hypothesis, we expressed channelrhodopsin (ChR2) in all GPe 
neurons under control of the hSyn promotor (hSyn-ChR2) (Fig. 3-1a) and measured the efficacy 
of global GPe stimulation to rescue immobility and bradykinesia in bilaterally DD mice (see 
methods, Fig. A1a-b, and A2a-c).  
 Even though GPe neurons exhibited the expected decrease in firing rate (Naive: 44.3 ± 
2.6 Hz, n = 73 neurons across 4 animals vs. bilateral DD: 24.6 ± 1.6 Hz, n = 62 neurons across 3 
animals, p < 0.0001, Kruskal-Wallis H test) and increase in irregularity after dopamine depletion 
(CVNaive: 0.63 ± 0.03 vs CVDD: 0.80 ± 0.03; p < 0.0001, Kruskal-Wallis H test) (Fig. A1c-e), 
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hSyn-ChR2 did not rescue movement (Fig. 3-1b-c), nor did it reduce bradykinesia (normalized to 
dopamine intact control: Pre: 0.27 ± 0.23 vs. Post10min: 0.29 ± 0.25, n = 4, p = 0.683, paired t-
test) (Fig. 3-1d).  
 
 
Figure 3-1 Global GPe stimulation does not rescue movement in DD mice.  
(a) Schematic of global optogenetic stimulation in the GPe. GPe projections to the SNr are represented as a dashed 
line to indicate omission of the subthalamic nucleus. Str, striatum; D1 and D2, populations expressing D1 and D2 
dopamine receptors. (b) Percentage of time spent in the immobile state before (Pre), during and after (Post) 
stimulation (n = 4). Stimulation epochs are indicated with vertical blue lines. (c) Overlay of immobility immediately 
before, during (Stim) and after each light pulse. (d) Movement velocities, normalized to those in dopamine-intact 
controls, before and after stimulation in b (t(3) = −0.450, P = 0.683, paired t-test). Bars denote population averages; 
connected circles show data for individual mice. (e) Schematic of direct-pathway stimulation with D1-ChR2. (f) 
Percentage of time spent in the immobile state before, during and after stimulation (n = 4). (g) Overlay of 
immobility immediately before, during and after each light pulse. (h) Movement velocities, normalized to 
dopamine-intact controls, before and after stimulation in f (t(3) = 4.441, P = 0.02, paired t-test). (i) Schematic of 
GPe network recording during global stimulation. (j) Light-evoked responses of ten example GPe multiunits. (k) 
Average multiunit responses (n = 68 across 3 animals) over the course of a 30-s optical stimulus, displayed as z-
score (t(67) = 1.6679, P = 0.0495, one-tailed t test). Shaded area, s.e.m. FR, firing rate. (l) Average firing rates 
(normalized to baseline) of units (n = 34 across 3 animals) held across all ten stimulations. Each bin denotes firing in 
30-s bins immediately before and after each stimulation (blue). Error bars, s.e.m. 
 
 63 
 This inability to rescue movement with global GPe stimulation could challenge 
predictions of the classic basal ganglia model(Albin et al., 1989, DeLong, 1990), but at least two 
other interpretations are possible. The first is that bilaterally DD mice are so impaired that they 
are no longer capable of robust movement. To address this possibility, we increased direct 
pathway activity by driving ChR2 expression in D1-spiny projection neurons (D1-ChR2) (Fig. 3-
1e, A2d-e). Consistent with previous results(Kravitz et al., 2010), D1-ChR2 relieved immobility 
in a predominantly light-locked manner (Fig. 3-1f-g). Some movement persisted after the 10th 
light pulse, but this effect was not significant (Pre: 82 ± 24% vs. Post10min: 63 ± 21%, n = 4, p 
= 0.15, paired t-test). When movement bouts did occur, velocities were significantly greater than 
before stimulation (normalized to dopamine intact controls: Pre: 0.25 ± 0.22 vs. Post10min: 0.91 
± 0.46, n = 4, p = 0.02, paired t-test) (Fig. 3-1h). These results demonstrate that bilaterally DD 
mice are still capable of robust movement, so this cannot account for the inability of global GPe 
stimulation to rescue movement.  
A second possibility is that our optogenetic stimulation does not effectively drive firing 
of GPe neurons. To test this, we recorded the responses of GPe neurons in vivo during optical 
stimulation with hSyn-ChR2 (see methods, Fig. 3-1i). Due to the large numbers of neurons 
responding, single unit activity could not be well isolated during stimulation, so these data reflect 
multiunit activity. On average, all units (n = 68/68 units across 3 animals) significantly increased 
in firing rate (z-score100 ms = 17.6 ± 1.2; z = 1.65, p < 0.05, one-tailed z-test) and achieved peak 
activation within ~1 sec (range: 0.1-9.7 s) (Fig. 3-1j-k). In a subset of recordings, we verified 
that neural responses in the GPe were stable across each of the 10 repeated stimulations (n = 34 
units across 3 animals) (Fig. 3-1l). These results confirm that hSyn-ChR2 was effective at 
increasing firing rates of GPe neurons, yet this did not rescue movement in DD mice. 
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3.3.2 Selective Activation of PV-GPe Neurons Restores Movement Persistently in DD 
Mice 
The finding that movement can be rescued during D1-ChR2 stimulation, but not by global GPe 
stimulation, challenges the classic rate-based basal ganglia model and motivated a more in-depth 
analysis of GPe circuitry. The GPe contains a heterogeneous population of neurons(Gittis et al., 
2014, Hegeman et al., 2016). Since these populations have different anatomical and 
physiological properties, we reasoned that they might make different contributions to behavior. 
As such, cell-specific interventions might be more effective than global ones. To test this 
hypothesis, we first restricted ChR2 expression to PV-containing GPe neurons (Fig. 3-2a, A3a-
b).  
Ten days to 2 weeks after viral injections, mice were bilaterally depleted and the 
prokinetic effects of PV-ChR2 stimulation were measured 3-5 days later. In contrast to global 
GPe stimulation, selective stimulation of PV-GPe neurons provided robust relief of immobility 
and bradykinesia (Fig. 3-2b-d, Video B1-2). In mice expressing a control fluorescent construct 
(DIO-EYFP), immobility was not reduced (Fig. 3-2b). Initial responses to PV-ChR2 were highly 
light-locked, but as stimulation progressed, continuous movement gradually accumulated 
between light pulses (Fig. 3-2b-c). By the 10th light pulse, PV-ChR2 had reduced immobility to 
the same degree as D1-ChR2 (10th Stim: PV-ChR2: 21 ± 20%, n = 10 vs. D1-ChR2: 17 ± 23%, 
n = 4, p = 0.995, Sidak’s post hoc test). While the effects of D1-ChR2 decayed shortly after stim, 
the effects of PV-ChR2 persisted significantly after the 10th stimulation (Pre: 81 ± 21% vs. 
Post10min: 28 ± 16%, n = 10, p < 0.0001, paired t-test). Movement velocities were also 
significantly increased (normalized to dopamine intact controls: Pre: 0.26 ± 0.10 vs. Post10min: 
1.04 ± 0.67, n = 10, p < 0.0001, paired t-test) (Fig. 3-2d).  
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Figure 3-2 Selective stimulation of PV-GPe rescues movement persistently in DD mice.  
(a) Schematic of optogenetic stimulation of PV-ChR2. Str, striatum. (b) Percentage of time spent in the immobile 
state before (Pre), during and after (Post) stimulation (PV-ChR2: n = 10, PV-EYFP: n = 8). (c) Overlay of 
immobility immediately before, during (Stim) and after each light pulse. (d) Movement velocities, normalized to 
those in dopamine-intact controls, before and after stimulation in b (t(9) = 6.757, *P = 0.00008, paired t-test). Bars 
denote population averages; connected circles show data for individual mice. (e) Duration of prokinetic effects of 
PV-ChR2 (n = 10) and D1-ChR2 (n = 4) stimulation (main effecttime: F(6,54) = 7.672, P < 0.0001; main 
effectcondition: F(1,9) = 10.04, P = 0.0114; interaction effecttime×condition: F(6,54) = 6.793, P < 0.0001; two-way 
repeated-measures ANOVA). (f) Percentage of animals significantly more mobile than baseline (rescued) after D1-
ChR2 or PV-ChR2 over the post-stimulation period. Blue bar (Stim) represents full optogenetic manipulation. (g) 
Cumulative success rate over the 5-min trial for PV-ChR2 (n = 8 of 10) and PV-EYFP (n = 1 of 5) mice to reach 
food dish at far end of cage (χ2(1) = 5.000, P = 0.0253, chi-squared test). (h) Comparison of behavioral patterns 
expressed by PV-ChR2 mice (n = 10) during the Post period in b compared to dopamine-intact controls (n = 7). The 
average time engaged in each behavior is expressed as a percentage of total time. Only immobility (*P = 0.003, 
Mann–Whitney U) and rearing (*P = 0.0001, Mann–Whitney U) were significantly different between conditions. 
Error bars, s.e.m. 
 
To test the duration of the prokinetic effects of PV-ChR2, a subset of mice were left in 
the open field for 3 hrs after stimulation (n = 7) (Fig. 3-2e-f); 4 out of 7 mice remained highly 
mobile for the duration of the test (Fig. 3-2f) and immobility (averaged across all mice, n = 7) 
was significantly reduced for the entire 3 hrs (Fig. 3-2e). When mice were returned to their home 
cage after stimulation, locomotioned ramped down within minutes. However, when mice were 
placed at one end of a 30 x 20 cm cage with food and water positioned at the other end, 8 out of 
10 PV-ChR2 mice reached the food within 5 min (range: 0.08 – 3.9 min) whereas only 1 out of 5 
PV-EYFP mice reached the food (latency = 0.58 min) (p = 0.03, Chi-squared test) (Fig. 3-2g). 
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Combined, these results demonstrate that the prokinetic effects of PV-ChR2 stimulation are long 
lasting and persist for hours after stimulation.  
To characterize the behavioral patterns expressed by PV-ChR2 mice, open field 
behaviors were manually scored during the 10 min post stimulation period. Overall, behavioral 
patterns were remarkably similar between PV-ChR2 mice and dopamine intact controls (Fig. 3-
2h). Control (n = 7) and PV-ChR2 (n = 10) mice spent similar percentages of time walking 
(Control: 48 ± 6% vs. PV: 52 ± 25%; p = 0.6, Mann Whitney U), grooming (Control: 6 ± 4% vs. 
PV: 5 ± 4%; p = 0.734, Mann Whitney U) and performing fine movements (Control: 10 ± 4% vs. 
PV: 8 ± 7%; p = 0.270, Mann Whitney U). On average, walking bouts were longer in PV-ChR2 
mice (6.8 ± 4.9 sec) compared to controls (3.1 ± 0.48 sec, p = 0.043, Mann Whitney U). Rearing 
was not rescued by stimulation (Control: 27 ± 9% vs. PV: 0.6 ± 1%; p = 0.0001, Mann Whitney 
U) and PV-ChR2 mice spent more time immobile compared to controls (Control: 9 ± 4% vs. PV: 
33 ± 19%; p = 0.003, Mann Whitney U). Furthermore, PV-ChR2 mice retained a hunched 
posture and irregular gait (Video B2), suggesting that stimulation is more effective at alleviating 
bradykinesia/immobility than postural/gait symptoms.  
Because the severity of motor symptoms induced by bilateral DD restricted our 
experimental time window to 3-5 days after depletion, we performed a number of control 
experiments to ensure that behavioral rescue was specific for symptoms related to dopamine loss, 
and not symptoms induced by other factors such as acute inflammation. First, to control for the 
effects of inflammation, dopamine-intact mice were injected with lipopolysaccharide (LPS), an 
inflammatory agent, in the MFB(Herrera et al., 2000). Five days after injections of LPS, mice 
exhibited no locomotor deficits in the open field and PV-ChR2 stimulation had no effects on 
immobility (Fig. A4a). Second, we observed that the persistent component of behavioral rescue 
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could not be induced in mice with partial dopamine depletions (mice with >20% striatal TH left 
on either side) (Fig. A4b-f), suggesting the long-lasting prokinetic effects of PV-ChR2 are 
specific to the dopamine depleted state of the mouse and not other factors associated with our 
depletion protocol. Third, consistent with data from partially DD mice, PV-ChR2 stimulation in 
unilaterally DD mice (14 days post depletion) did not alter their behavior persistently (Fig. A4g-
i). Combined, these results demonstrate that the long-lasting prokinetic effects of PV-ChR2 are 
specifically induced only under conditions of advanced dopamine loss.  
3.3.3 Neuronal Responses In The GPe During PV-ChR2 Stimulation 
Our behavioral results demonstrate that movement is restored when PV-GPe neurons are 
stimulated selectively, but not when they are stimulated with all other GPe neurons (hSyn-
ChR2). To investigate how PV-ChR2 stimulation differs at the network level from hSyn-ChR2 
stimulation, we recorded responses of neurons in vivo during PV-ChR2 stimulation (Fig. 3-3a). 
To identify putative PV-GPe neurons, neurons were first classified as ChR2+ or ChR2- on the 
basis of their short-latency responses to brief (5 ms) optical pulses (see methods, Fig. A5a). 
Characteristic firing patterns and waveform distributions of ChR2+ and ChR2- neurons are 
summarized in Fig. A5b-c. Because the average firing rate of our putative PV-GPe population 
(24 ± 4 Hz, n = 18 across 3 animals) was lower than what has been reported by other 
groups(Dodson et al., 2015, Mallet et al., 2016), we validated our optical identification strategy 
in dopamine intact mice (Fig. A5d). In dopamine intact control mice, the average firing rate of 
the PV-GPe population was 46 ± 2 Hz, consistent with results from previous studies (48 ± 3 
Hz(Dodson et al., 2015), and 47 ± 6 Hz (Mallet et al., 2016)). These results suggest that the 
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lower firing rates of putative PV-GPe neurons in our study are due to changes in population 
activity induced by dopamine loss, and not errors in neuronal classification.  
In DD mice, 18 out of 18 ChR2+ neurons (putative PV-GPe) responded to 30 sec optical 
pulses with sustained increases in firing rates (Fig. 3-3b-c), averaging 24 ± 4 Hz before 
stimulation and 52 ± 8 Hz during stimulation (p < 0.0002, paired t-test) (Fig. 3-3d). A subset of 
recordings that were stable enough to track single units across a 10-pulse stimulation paradigm 
(n = 7 across 3 animals) revealed that responses were consistent across all 10 pulses (Fig. 3-3e). 
In contrast, most (14/21) ChR2- neurons were inhibited during optical pulses (Fig. 3-3b-c), 
averaging 30 ± 3 Hz before stimulation and 18 ± 2 Hz during stimulation (p < 0.0004, paired t-
test) (Fig. 3d). Firing rates of the remaining (7/21) ChR2- neurons were not significantly 
modulated (data not shown). A subset of recordings that were stable enough to track inhibited 
units across a 10-pulse stimulation paradigm (n = 4 across 2 animals) revealed that inhibitory 
responses were consistent across all 10 pulses (Fig. 3-3e). 
These data reveal a key difference between the effect of PV-ChR2 vs. hSyn-ChR2 on 
population dynamics within the GPe. PV-ChR2 produces a bidirectional response that transiently 
elevates the firing of PV-GPe neurons but suppresses the firing of other GPe neurons, a 
dissociation that is occluded during global stimulation with hSyn-ChR2. To test whether this 
dissociation is critical for the induction of behavioral rescue, we sought to mimic this effect by 
inhibiting a subset of neurons directly with archaerhodopsin (Arch). Because the firing rates and 
waveforms of ChR2- neurons were highly overlapping with those of ChR2+ neurons (Fig. A5b-
c), we reasoned that both subtypes are part of the prototypical population(Dodson et al., 2015, 
Mallet et al., 2016). PV-GPe neurons constitute a major fraction of this population, but neurons 
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expressing Lhx6 represent a second, partially non-overlapping fraction(Mastro et al., 2014, 
Hernandez et al., 2015, Oh et al., 2016b) (Fig. A6a-b).  
 
Figure 3-3 Local response during PV-ChR2 stimulation directly inhibits other high-firing GPe neurons.  
(a) Schematic of GPe network recording during PV-ChR2 stimulation. (b) Light-evoked responses of ten single 
units during onset of a 30-s pulse. (c) Average z-score of excited (red, n = 18 of 39 across 3 animals) and inhibited 
(blue, n = 14 of 39) neurons during a 30-s optical pulse. Shaded area, s.e.m. FR, firing rate. (d) Firing rates of 
individual neurons before, during (time 0) and in 10-s bins after a 30-s light pulse (excited: t(17) = −4.913, *P < 
0.0001, paired t-test, inhibited: t(13) = 4.789, *P < 0.0001, paired t-test). Population averages are shown as thick, 
colored lines. (e) Average firing rates of units across all ten 30-s pulses for excited (top, n = 5 across 3 animals) and 
inhibited units (bottom, n = 4 across 2 animals). Shaded bars (blue) indicate periods of stimulation and each point 
represents 30-s bins immediately before, during and after the stimulation. Error bars, s.e.m. (f) Schematic of GPe 
network during Lhx6-Arch stimulation. (g) Light-evoked responses of ten single units during onset of a 30-s pulse. 
(h) Average z-score of inhibited (blue, n = 27 of 42 across 3 animals) and unchanged (gray, n = 15 of 42) neurons 
during a 30-s optical pulse. Shaded area, s.e.m. (i) Firing rates of individual neurons before, during (time 0) and in 
10-s bins after a 30-s light pulse (inhibited: t(26) = 9.888, *P < 0.0001, paired t-test, no change: t(14) = −1.126, P = 
0.279, paired t-test). Population averages are shown as thick colored lines. (j) Average firing rates of inhibited units 
held across all ten 30-s pulses (n = 11 across 3 animals). Shaded bars (green) indicate periods of stimulation and 
each point represents 30-s bins immediately before, during and after the stimulation. Error bars, s.e.m. (k) Summary 
of average firing rates before, during and after 30-s stimulations of PV-ChR2 and Lhx6-Arch. 
 
To measure the impact of inhibiting Lhx6-GPe neurons on population activity in the GPe, 
we performed in vivo recordings in Lhx6-Cre mice two weeks after viral-mediated expression of 
Flex-Arch (Fig. 3-3f). Neurons were classified as Arch+ or Arch- based on their response to 1 
sec optical pulses of green light (see methods, Fig. A5e). Characteristic firing patterns and 
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waveform distributions of Arch+ and Arch- neurons were highly overlapping and are 
summarized in Fig. A5f-g.  
In response to 30 sec optical pulses, 27 out of 27 Arch+ neurons responded with 
sustained decreases in firing rates (Fig. 3-3g-h), averaging 29 ± 3 Hz before stimulation and 6 ± 
2 Hz during stimulation (p = 2.68 x 10-10, paired t-test) (Fig. 3-3i). A subset of recordings that 
were stable enough to track single units across a 10-pulse stimulation paradigm (n = 11 across 3 
animals) revealed that responses were consistent across all 10 pulses (Fig. 3-3j). The remaining 
15 out of 15 neurons were Arch- and showed no net change in firing rate during optical 
stimulation (Fig. 3-3g-i). Although some neurons exhibited sharp firing rate increases at the 
onset of a light pulse, this effect was transient, and often did not persist for >100 ms (Fig. 3-3h). 
These results demonstrate that Lhx6-Arch, like PV-ChR2, transiently dissociates population 
activity in the GPe, but with different effects on absolute firing rate (Fig. 3-3k). 
3.3.4 Selective Inhibition of Lhx6-GPe Neurons Restores Movement Persistently in DD 
Mice 
To test whether the transient dissociation of GPe activity produced by Lhx6-Arch was also 
sufficient to induce behavioral rescue, we assessed its effects on immobility and bradykinesia of 
DD mice in the open field (Fig. 3-4a-d, A3c). Initially, mice were highly immobile (Pre: 86 ± 
11%, n = 9), but over the course of 10 stimulations, Lhx6-Arch reduced immobility to a similar 
degree as PV-ChR2 (10th pulse: Lhx6-Arch: 28 ± 38%, n = 9 vs. PV-ChR2: 21 ± 20%, n = 10, p 
= 0.80, Tukey’s post hoc test) (Fig. 3-4b,f, Video B3). Immobility was not reduced in mice 
expressing a control fluorescent construct (DIO-EYFP) (Fig. 3-4b), nor was it induced by 
globally inhibiting all GPe neurons with CAG-Arch (Fig. 3-4h-j, A3d). 
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Intriguingly, Lhx6-Arch induced the gradual, persistent component of behavioral 
recovery but not the early, light-locked component present in PV-ChR2 mice. Bradykinesia was 
also greatly reduced (Pre: 0.22 ± 0.08 vs. Post10min: 0.85 ± 0.45, n = 9, p = 0.002, paired t-test) 
(Fig. 3-4d). Ten minutes after the last stimulation, Lhx6-Arch mice remained highly mobile, 
spending only 34 ± 21% (vs. Pre: 86 ± 11%, n = 9, p = 0.012, Tukey’s post hoc test) of their time 
in the immobile state. Similar to the long-lasting effects of PV-ChR2, immobility in Lhx6-Arch 
mice remained significantly reduced for hours after stimulation (Post3hr: Lhx6-Arch: 45 ± 11%, 
n = 5 vs. PV-ChR2: 41 ± 36%, n = 7, p =0.990,Tukey’s post hoc test) (Fig. 3-4f-g) and 3 out of 5 
Lhx6-Arch mice remained highly mobile for the duration of the test (Fig. 3-4g).  
 
Figure 3-4 Selective suppression of Lhx6-GPe rescues movement persistently in DD mice.  
(a) Schematic of optogenetic inhibition of Lhx6-GPe neurons. Str, striatum. (b) Percentage of time spent in the 
immobile state before (Pre), during and after (Post) Lhx6-Arch (n = 9) and Lhx6-EYFP (n = 7). (c) Overlay of 
immobility immediately before, during (Stim) and after each light pulse. (d) Movement velocities, normalized 
(Norm) to those in dopamine-intact controls, before and after stimulation in b (*P = 0.002, paired t-test). Bars 
denote population averages; connected circles show data for individual mice. (e) Comparison of behavioral patterns 
expressed by Lhx6-Arch (n = 7) mice during the post-stimulation period compared to those of dopamine-intact 
controls (n = 6). The average time engaged in each behavior is expressed as a percentage of total time. Only 
immobility and rearing (P = 0.001, Mann–Whitney U) were significantly different between conditions. (f) Duration 
of prokinetic effects of Lhx6-Arch (n = 5) and PV-ChR2 (n = 7), plotted for reference (main effecttime: F(7,70) = 
7.994, P < 0.0001; main effectcondition: F(1,10) = 0.5855, P = 0.462; interaction effecttime×condition: F(7,70) = 1.358, P = 
0.2367; two-way repeated-measures ANOVA). (g) Percentage of animals significantly more mobile than baseline 
(rescued) after Lhx6-Arch or PV-ChR2 over the post-stimulation period. Green bar (Stim) represents full 
optogenetic manipulation. (h) Schematic of optogenetic inhibition of all GPe neurons. (i) Percentage of time spent in 
the immobile state before, during and after CAG-Arch (n = 4) and Lhx6-EYFP (n = 7). (j) Movement velocities, 
normalized to those of dopamine-intact controls, before and after stimulation in i (P = 0.393, paired t-test). Error 
bars, s.e.m. 
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Behavioral patterns in Lhx6-Arch mice were similar to those of dopamine intact controls 
(Fig. 3-4e). Control (n = 6) and Lhx6-Arch mice (n = 7) spent similar percentages of time 
walking (Control: 42 ± 12% vs. Lhx6: 44 ± 28%; p = 0.886, Mann Whitney U), grooming 
(Control: 6.9 ± 7.7% vs. Lhx6: 11.2 ± 9.2%, p = 0.568, Mann Whitney U) and performing fine 
movements (Control: 21 ± 9% vs. Lhx6: 18 ± 9%, p = 0.445, Mann Whitney U), but rearing 
behavior was not recovered (Control: 23 ± 10% vs. Lhx6: 0.3 ± 0.3%, p = 0.001, Mann Whitney 
U). Lhx6-Arch mice spent a wide range (7-50%) of time in the immobile state (Control: 7.6 ± 
2.0% vs. Lhx6: 26.5 ± 18.3%, p = 0.101, Mann Whitney U). Walking bouts in Lhx6-Arch mice 
were significantly longer compared to control (Control: 2.7 ± 0.8 ms vs. Lhx6: 5.6 ± 2.4 ms, p = 
0.02, Mann Whitney U) and they walked with a hunched posture and shuffling gait (Video B4). 
Combined, our behavioral results suggest that transiently dissociating the activity of GPe 
neurons with Lhx6-Arch induces a gradual, long-lasting recovery of movement that is 
qualitatively and quantitatively similar to that induced by PV-ChR2. 
3.3.5 Persistent Behavioral Rescue Depends on the Ratio of Lhx6 and PV Activity 
Thus far, our results have shown that movement can be persistently rescued by manipulations 
that dissociate the activity of PV-GPe neurons above that of Lhx6-GPe neurons. But because 
these subpopulations are partially overlapping at the molecular level (Fig. A6a-b), we wanted to 
determine whether their effects were truly segregated at the behavioral level. To test this, we 
assessed the prokinetic effects of inverse manipulations: Lhx6-ChR2 and PV-Arch. In mice 
stimulated with Lhx6-ChR2 (Fig. 3-5a, A3e), some relief from immobility was observed in 3 out 
of 5 mice during the stimulation period (Pre: 91 ± 13% vs. 10th Stim: 47 ± 46 %, n = 5, p = 
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0.067, Tukey’s post hoc test), but this effect did not persist beyond 30 min. after stimulation 
(Pre: 91 ± 13% vs. Post30 min: 72 ± 37%, n = 5, p = 0.684, Tukey’s post hoc test) (Fig. 3-5b-c). 
 
 
Figure 3-5 The induction of persistent behavioral rescue is cell-type specific.  
(a) Schematic of optogenetic stimulation of Lhx6-GPe neurons. Str, striatum. (b) Percentage of time spent in the 
immobile state before, during and after Lhx6-ChR2 (n = 5) and Lhx6-EYFP (n = 7) stimulation. (c) Duration of 
prokinetic effects in Lhx6-ChR2 mice. Data from PV-ChR2 (n = 10) and D1-ChR2 (n = 4) are replotted for 
reference (main effecttime: F(6,78) = 10.25, P < 0.0001; main effectcondition: F(2,13) = 7.177, P = 0.0079; interaction 
effecttime×condition: F(12,78) = 3.947, P < 0.0001, two-way repeated-measures ANOVA). (d) Schematic of optogenetic 
suppression of PV-GPe neurons. (e) Percentage of time spent in the immobile state before, during and after PV-Arch 
stimulation (n = 4). (f) Schematic of GPe manipulations that globally alter GPe physiology and those that shift the 
relative balance of PV and Lhx6 neurons to successfully induce behavioral rescue (PV-ChR2, Lhx6-Arch). Error 
bars, s.e.m. 
 
In mice stimulated with PV-Arch (Fig. 3-5d, A3f), optogenetic suppression of PV-GPe 
neurons did not rescue movement (Fig. 3-5e). Immobility in PV-Arch mice was 94 ± 4% before 
the first stimulation and 92 ± 8% during the 10th stimulation (n = 5, p = 0.448, paired t-test) and 
no persistent effects were observed (Fig. 3-5e). Taken together, these results confirm that the 
induction of long-lasting behavioral recovery is cell-type specific, and is induced by 
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interventions that dissociate the firing rates of PV-GPe neurons above that of Lhx6-GPe neurons 
(Fig. 3-5f). 
3.3.6 PV-ChR2 and Lhx6-Arch Reverse Pathological Burst Firing in SNr 
How do transient imbalances between the firing rates of two subpopulations of GPe neurons 
produce a long-lasting effect on movement? To study the impact of GPe interventions on the 
basal ganglia circuit, we recorded neural activity in the substantia nigra reticulata (SNr), the 
major basal ganglia output nucleus in rodents.   
A pathological hallmark of SNr dysfunction following dopamine depletion is an increase 
in burst firing and the percentage of bursting neurons(Soares et al., 2004, Rubin et al., 2012, 
Wang et al., 2016). Consistent with these findings, we observed a rightward shift in the 
proportion of bursting neurons in DD mice compared to dopamine intact controls (p = 0.005 , K-
S two sample test) (Fig. 3-6a-b). To test if optogenetic stimuli that rescue movement reduce the 
proportion of bursting neurons, we recorded from the SNr before, during, and after stimulation 
(Fig. 3-6c-d). PV-ChR2 induced a leftward shift in the distribution of bursting neurons in the 
SNr (p = 0.005, K-S two sample test) (Fig. 3-6e). This effect was most pronounced for 'highly 
bursty' units, as identified by burst frequencies that exceeded 1 median absolute devation (MAD) 
above the median (Fig. 3-6f). The fraction of highly bursting neurons was reduced from 27% pre 
stimulation to 10% post stimulation (Pre: n = 22/81 vs. Post: n = 6/58 across 3 animals, p = 0.044 
, chi-squared test) (Fig. 3-6g). In contrast, hSyn-ChR2 did not shift the distribution of bursting 
neurons (p = 0.188, K-S two sample test) (Fig. 3-6h); 31% of units were classified as highly 
bursty pre stimulation compared to 20% post stimulation (Pre: n = 17/55 vs. Post: n = 14/69 
across 3 animals, p = 0.295 , chi-squared test) (Fig. 3-6i-j). In recordings stable enough to track 
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the activity of single units across all 10 light pulses, a reduction in the number of bursts was 
apparent at the level of individual neurons recorded in PV-ChR2 mice (Fig. 3-6k), but not in 
hSyn-ChR2 mice (Fig. 3-6l). Intriguingly, bursts diminished gradually over the first 2-4 stimuli, 
mirroring the kinetics of behavioral rescue in the open field. 
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Figure 3-6 PV-ChR2 and Lhx6-Arch reverse pathological bursting activity persistently.  
(a) Cumulative distribution function (CDF) plots of burst firing in the SNr of dopamine intact (naive; solid line) and 
bilaterally DD mice (acute; dotted line). *P = 0.005. (b) Representative raster of single-unit activity in naive and 
acute conditions. (c) Schematic of simultaneous GPe stimulation (bilateral, not depicted) and SNr recording. (d) 
Representative SNr single-unit activity before stimulation (Pre), between stimulations (Inter-stim) and after 
stimulation (Post) of the PV-GPe neurons. (e) Distribution of burst firing before and after PV-ChR2 stimulation. 
Acute distribution (dotted line) replotted for reference. *P = 0.005. (f) Histogram of burst firing before (top, 2 h) and 
after (bottom, 3 h) PV-ChR2 stimulation. (g) Fraction of bursty units before and after PV-ChR2 stimulation. *P = 
0.044. (h) Distribution of burst firing before and after hSyn-ChR2 stimulation. (i) Histogram of burst firing before 
(top) and after (bottom) hSyn-ChR2 stimulation. (j) Fraction of bursty units before and after hSyn-ChR2 stimulation. 
(k,l) Single-unit burst activity normalized to the pre-stimulation baseline and plotted before, during and after PV-
ChR2 (n = 7 across 3 animals) or hSyn-ChR2 (n = 3 across 2 animals). Error bars, s.e.m. (m) Distribution of burst 
firing before and after Lhx6-Arch inhibition. *P = 0.005. (n) Histogram of burst firing before (top) and after 
(bottom) Lhx6-Arch inhibition. (o) Fraction of bursty units before and after Lhx6-Arch inhibition. *P = 0.0006. (p) 
Fraction of bursty units over the course of the 3-h post-stimulation period across 3 animals per condition. Error bars, 
s.e.m. 
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To test whether Lhx6-Arch works through a similar mechanism, we repeated experiments 
in Lhx6-Arch mice. Consistent with the effects of PV-ChR2, Lhx6-Arch produced a leftward 
shift in the distribution of bursting neurons in the SNr (p = 0.005, K-S two sample test) (Fig. 3-
6m) and the fraction of highly bursting neurons was reduced from 31% pre stimulation to 3% 
post stimulation (Pre: n = 9/29 vs. Post: n = 2/69 across 3 animals, p = 0.0006 , chi-squared test) 
(Fig. 3-6n-o).  
To determine how long burst attenuation persisted after stimulation, we separated the 
population activity into one hour time bins and calculated the fraction of bursty neurons over 
time. Consistent with the persistent effects on behavior, the fraction of bursty neurons across the 
population remained persistently reduced for hours after stimulation (Pre vs. Post2hr: PV-ChR2: 
p = 0.007, Lhx6-Arch: p = 0.003, Dunnett’s multiple comparisons test), and only begins to drift 
back to pre-stimulation levels by ~3 hrs after stimulation (Pre vs. Post3hr: PV-ChR2: p = 0.105, 
Lhx6-Arch: p = 0.001, Dunnett’s multiple comparisons test) (Fig. 3-6p). These data suggest a 
mechanism through which PV-ChR2 and Lhx6-Arch persistently rescue movement through a 
long-lasting normalization of basal ganglia output pattern. We also considered effects of 
stimulation on SNr firing rates, and although burst firing decreased, there was no change in the 
firing rate before and after PV-ChR2 and Lhx6-Arch (Fig. A7). In contrast, hSyn-ChR2 induced 
a pronounced decrease in the firing rate but no change to the overall proportion of highly bursty 
neurons (Pre vs. Post1-3hr: p > 0.1, Dunnett’s multiple comparisons test).  
Taken together, these results suggest that transient cell-specific interventions in the GPe 
induce long-lasting reductions in the pathological activity of basal ganglia output neurons in the 
SNr that persist for hours beyond stimulation. 
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3.4 DISCUSSION 
Here, we demonstrate that cell-specific interventions in the GPe induce robust, long-lasting 
recovery of motor function in DD mice. Manipulations that transiently elevate the firing of PV-
GPe neurons above that of Lhx6-Arch neurons reverse pathological burst firing in the SNr and 
ameliorate symptoms of immobility and bradykinesia for hours beyond stimulation. These results 
establish the behavioral significance of cell-type heterogeneity in the GPe, with potential 
implications for the treatment of PD.  
Nearly thirty years ago, the discovery that striatal neurons can be molecularly divided 
into D1 and D2-subpopulations provided a cellular basis for the direct/indirect pathway model of 
the basal ganglia that has long dominated our conceptual framework(Gerfen et al., 1990). 
However, with the exception of neuronal diversity in the striatum, the classic direct/indirect 
pathway model treats all other downstream nuclei as relay structures, an oversimplification 
whose limits have become increasingly apparent as techniques to study circuit function become 
more sophisticated. The GPe contains different cell populations(Gittis et al., 2014, Hegeman et 
al., 2016), but this knowledge has been slow to translate into therapeutic strategies. Here, 
leveraging tools to optogenetically target subpopulations of GPe neurons, we can induce long-
term recovery of motor function in DD mice.  
Strategies that persistently restored movement shared a common mechanism of elevating 
the firing rates of PV-GPe neurons relative to that of Lhx6-GPe neurons (PV-ChR2, Lhx6-Arch). 
Interventions that activated or suppressed all GPe neurons were not effective (hSyn-ChR2, CAG-
Arch), nor were interventions that elevated the firing rates of Lhx6-GPe neurons relative to PV-
GPe neurons (Lhx6-ChR2, PV-Arch). Thus, despite some overlap between the Lhx6 and PV 
subpopulations at the molecular level(Abdi et al., 2015, Dodson et al., 2015, Hernandez et al., 
 79 
2015, Hegeman et al., 2016, Oh et al., 2016b), the behavioral effects produced by manipulating 
these populations are well segregated.  
The GPe’s impact on movement is thought to be mediated by its influence over basal 
ganglia output nuclei, predominantly the SNr in rodents(Albin et al., 1989, DeLong, 1990, Smith 
et al., 1998a). Under dopamine depleted conditions, neurons in the basal ganglia become more 
rhythmic and bursty, impairing basal ganglia output(Bevan et al., 2002, Rubin et al., 2012). 
Attenuation of pathological activity is well correlated with the therapeutic effects of DBS on 
bradykinesia and rigidity(Kuhn et al., 2006, Weinberger et al., 2006, Hammond et al., 2007, 
Vitek et al., 2012). The dissociation of pallidal subpopulations –elevating the activity of PV-GPe 
above Lhx6-GPe neurons – and the subsequent removal of pathological activity in the SNr, may 
be a possible mechanism for DBS. Although acute toxin models do not replicate all the features 
of a complex human disorder such as PD, they provide key insights into the function of neural 
circuits under conditions of low dopamine. The cardinal motor symptoms of PD such as 
immobility and bradykinesia do not arise until dopamine levels have decreased by ~70%, 
highlighting the need to discover strategies to restore motor function, even at advanced stages of 
dopamine loss(Bernheimer et al., 1973, Riederer and Wuketich, 1976, Betarbet et al., 2002, 
Deumens et al., 2002, Fahn, 2003).  
It has long been assumed that the prokinetic effects of DBS are limited to the stimulation 
period, with symptoms (and pathological activity) rapidly returning within minutes after 
stimulation. However, a modified DBS protocol, called coordinated reset (CR-DBS), has been 
shown to provide some prokinetic benefits that persist for hours, or even days, after stimulation 
in both MPTP primate models(Tass et al., 2012, Wang et al., 2016) and human PD 
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patients(Adamchic et al., 2014). The ability to destabilize the network by shifting the balance of 
neuronal subpopulations may be sufficient to rescue motor function.  
Although we do not know whether GPe stimulation engages similar mechanisms, the 
GPe is a central node for the amplification and propagation of pathological network oscillations 
in PD(Bergman et al., 1998, Bevan et al., 2002, Kita, 2007, Holgado et al., 2010, Vitek et al., 
2012, Corbit et al., 2016). Our data identify PV and Lhx6-GPe neurons as critical nodes within 
the basal ganglia circuit for the induction of long-lasting attenuation of pathological activity in 
the SNr. The convergent effects of PV and Lhx6-GPe neurons on the SNr could be mediated via 
their direct projections to the nucleus, or via their indirect projections by way of the STN, a 
nucleus which is differentially innervated by Lhx6 vs. PV subpopulations(Mastro et al., 2014). 
Elucidating the circuit and synaptic mechanisms that give rise to pathological rhythmicity in 
disease, and discovering interventions to best counteract this rhythmicity, is an important area of 
research in the field.  
3.4.1 Conclusions 
In conclusion, our results demonstrate that cell-specific, but not global interventions in the GPe 
induce long-lasting behavioral rescue and physiological restoration of basal ganglia output in DD 
mice. These results establish important functional distinctions between subpopulations of GPe 
neurons, delineated in part by their expression of Lhx6 and PV. These results reconcile a number 
of conflicting reports in the literature: that successful DBS can either increase or decrease firing 
rates of GPe neurons(Bar-Gad et al., 2004, Chin and Hutchison, 2008, Erez et al., 2009, 
Bugaysen et al., 2011), that DBS directly in the GPe can reduce bradykinesia(Johnson et al., 
2012, Vitek et al., 2012) but restoring autonomous firing after DD has no effect(Chan et al., 
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2011). Finally, because the proportion of PV-GPe neurons in humans is similar to that in 
mice(Hardman and Halliday, 1999), our results suggest that interventions that preferentially 
increase their activity relative to other GPe neurons might provide more persistent prokinetic 
benefits than current treatments.  
3.5 ACKNOWLEDGEMENTS  
The authors thank V. Corbit and T. Whalen for Matlab analysis scripts and B. Rogowski for 
surgical support and behavioral video editing. We also thank N. Kessaris and H. Zeng for their 
gifts of the Lhx6-iCre and Pvalb-2A-Cre mice, respectively. This work was supported by NIH 
grants F31 NS090745-01 (K.M.), F31 NS093944-01 (A.W.), R00 NS076524, NSF grant DMS 
1516288, and grants from the Brain and Behavior Research Foundation (National Alliance for 
Research on Schizophrenia and Depression Young Investigator Grant), the Parkinson’s Disease 
Foundation, and the NIH Intramural Research Program. 
 82 
4.0  SUMMARY AND CONCLUSIONS 
By understanding and interrogating cellular diversity, we gain clarity into the physiological and 
functional capabilities of neural circuits. As discussed in the introduction, the use of transgenic 
animals and bevy of emerging tools available to isolate, manipulate and control distinct 
populations of neurons have revolutionized neuroscience. We are gaining an incredible insight 
into the underlying structure of neural circuits that previously was inaccessible. Here, we defined 
cellular diversity within the GPe, a nucleus within the motor-suppressing pathway of the basal 
ganglia, and investigated its contributions to circuit function in health and disease.  
In Chapter 2, we utilize transgenic animals to subdivide the GPe into two distinct 
populations of neurons based on their expression of parvalbumin (PV-GPe) or Lim homeobox 6 
(Lhx6-GPe). These neurons differed across a range of topographic, physiological and anatomical 
factors. Most notably, PV-GPe neurons were more often found within the lateral GPe, had a 
greater response to current, and had a unique projection to the parafascicular nucleus of the 
thalamus. Lhx6-GPe neurons were more often found in the medial GPe, had lower spontaneous 
firing rates and sent a denser projection to both the striatum and dopamine neurons within the 
substantia nigra pars compacta. This study was the first to utilize transgenic mice to define 
distinct populations of GPe neurons and provided tools to understand their contributions to 
behavior in health and disease. 
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The GPe is highly implicated in the initiation, propagation and maintenance of 
dysfunction within basal ganglia (Lozano et al., 2000, Kita, 2007, Obeso et al., 2008). Therefore; 
we assessed the functional contribution of the GPe cell-types in a model of Parkinson’s disease. 
By using targeted viral expression of optogenetics, we activated or inhibited GPe, globally or 
cell-type specifically, to determine whether GPe manipulation would provide a therapeutic 
benefit. As shown in Chapter 3, cell-type specific but not global manipulations rescues motor 
function in dopamine-depleted mice. Specifically, the PV-GPe population must be elevated 
above Lhx6-GPe neurons, for the successful induction of a persistent motor recovery. Consistent 
with the long-lasting motor recovery, the activation of PV-GPe or inhibition of Lhx6-GPe 
neurons attenuated burst firing within the basal ganglia output nucleus that persisted for hours 
and hours after the stimulation. These results demonstrate the distinct functional contributions of 
these two-partially overlapping populations and uncover a potential therapeutic intervention 
during disease.  
Taken together, these results demonstrate the wide range of differences that exist within 
the GPe cell-types and its potential to disrupt pathological activity and behavior within the 
disease state. The main goal of this discussion is two-fold: 1) discuss the evolving and often-
controversial field of cellular heterogeneity within the GPe and 2) provide potential mechanisms 
for which the GPe cell-types exert profound therapeutic benefit during disease. Though these 
cell-types have their shortcomings and limitations; they have provided a great opportunity to 
break open a critical node within the basal ganglia and continue to understand how it influences 
behavior. 
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4.1 SHIFTING CELLULAR LANDSCAPE OF THE GPE 
Since the golden age of basal ganglia research, there has been evidence of neuronal 
heterogeneity within the GPe (see review by (Hegeman et al., 2016). Attempts have been made 
to classify GPe cell-types, but these criteria are often difficult to generalize across preparations 
(Nambu and Llinas, 1994, Cooper and Stanford, 2000, Kita, 2007, Deister et al., 2013), rely on 
postmortem cell-type identification (Hoover and Marshall, 1999, Sato et al., 2000, Hoover and 
Marshall, 2002), or rely on activity in disease states (Mallet et al., 2012). Over the last ten years, 
the field has capitalized on modern techniques to categorize GPe neurons and with it has brought 
a great deal of attention and some conflict to the GPe field. The goal of the following section is 
to highlight emerging GPe cell-type definitions and to identify areas that can be improved within 
future experiments.  
From the seminal GPe recordings within awake behaving monkeys (DeLong, 1971), 
there were two physiological distinct populations of neurons based on their spontaneous firing 
rates: ‘high-frequency discharge with pause’ and ‘low-frequency discharge with bursts’. 
Subsequent studies have studied these two populations of neurons extensively and have provided 
new tools to access and further delineate functionally-relevant distinctions.  
4.1.1 Low-Frequency Discharge with Bursts: Arkypallidal Population 
The slowly firing population that tends to fire in bursts makes up approximately 15-20% of 
pallidal neurons and express the opioid precursor preproenkephalin and the transcription factor 
FoxP2 (Mallet et al., 2012, Abdi et al., 2015, Dodson et al., 2015). They were recently termed 
the arkypallidal population due to their extensive projections to the dorsal striatum.  These 
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neurons send a massive net-like axonal projection synapses onto all cell-types within the striatum 
that was first described in non-human primates by Kita et al. (1999) and later confirmed within 
rodents (Mallet et al., 2012, Abdi et al., 2015, Dodson et al., 2015).  Furthermore, the majority of 
arkypallidal neurons originate from the lateral ganglion eminence (Dodson et al., 2015) and have 
been linked to the suppression of motor output (Glajch et al., 2016) by exerting a widespread 
‘stop’ signal in the striatum (Mallet et al., 2016). Though not the focus of this dissertation, the 
presence of these neurons provide a diversity in function that is in stark contrast to the 
widespread connections made by the remaining ~80% of neurons. These neurons and their 
emerging role in terminating behavioral sequences will influence the function of all other pallidal 
neurons.  
Future studies must unravel the relationship between the arkypallidal and remaining 
neuronal populations in the GPe. For instance, do these neurons receive a distinct set of inputs 
from cortex, striatum or thalamus? Are these neurons critical or specifically wired into the 
‘hyperdirect’ pathway (monosynaptic cortical input to STN)? How do GPe collaterals from 
distinct cell-types impact the function of these neurons in health and disease? By capitalizing on 
these distinct markers and physiological patterns, we are poised to capitalize on optical and 
physiological approaches to delineate their contributions in health and disease. 
4.1.2 High-Frequency Discharge with Pause: Prototypic Population 
Over the last five years, there has been a strong push to define the ‘high-frequency pausers’, or 
prototypic population utilizing currently available tools. The prototypic population is defined by 
dense projections to the subthalamic nucleus (STN) and the fast spontaneous firing rate exhibited 
in both in vivo (Mallet et al., 2012, Mallet et al., 2016, Mastro et al., 2017) and ex vivo 
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preparations (Nambu and Llinas, 1994, Cooper and Stanford, 2000, Mastro et al., 2014). The 
evidence strongly indicates that within the remaining 80% of neurons there exist multiple classes 
that may be separable based on molecular expression, anatomic connectivity or enhanced 
physiological parameters.  
Our study highlighted one of the first molecularly distinct populations of neurons, 
parvalbumin (PV)-expressing GPe neurons. Utilization of PV-expression had been used in 
previous studies (Bevan et al., 1998, Kita et al., 1999, Mallet et al., 2012) but the confirmation of 
its selectivity in transgenic animals provided a toolset that could be transferrable across 
experimental manipulations (Mastro et al., 2014, Hernandez et al., 2015). Recently, Oh et al. 
(2016b) created transgenic rats that expressed cre-recombinase by way of the PV-promotor and 
confirmed many previously established results (Bevan et al., 1998, Kita et al., 1999, Mallet et al., 
2012, Mastro et al., 2014, Abdi et al., 2015, Dodson et al., 2015). PV-GPe neurons make up 
approximately 35-55% of the total population which is similar to the amount reported within 
humans (Hardman and Halliday, 1999). Other studies have used a host of molecular markers 
with varying levels of distinction and overlap (Hegeman et al., 2016).  
As noted in a recent review, there is overlap between many of the neuronal markers but 
these distinguishable populations provide a new investigative tool to better understand how the 
GPe processes information and shapes behavior (Hegeman et al., 2016). While the arkypallidal 
population has been linked to the hyperdirect ‘stop’ pathway (Dodson et al., 2015, Mallet et al., 
2016), the role of other GPe neurons are still not well understood. Though it should be noted that 
even from the earliest recordings within the GPe, there has been brilliant work to understand how 
GPe neurons shape behavior. From in vivo recordings, GPe neurons have been shown to fire 
independently (Nini et al., 1995); with firing rates that are characterized by complex temporal 
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patterns and low correlation during movement (Delong et al., 1985, Wichmann et al., 1994, 
Jaeger et al., 1995, Bergman et al., 1998) that are related to the movement kinematics (Turner 
and Anderson, 1997). Though some brain areas may be able to contribute distinct functions to 
distinct cell-types, it is obvious that interaction between pallidal neurons, through powerful 
collaterals, may play a critical role in how GPe influences behavior. 
Dodson et al. (2015) observed no physiological and functional difference between their 
‘prototypic’ subdivisions in response to movement (Dodson et al., 2015). Briefly, neurons were 
subdivided based on their expression of PV, Lhx6, and an additional transcription factor Nkx2.1 
and recorded extracellularly in awake, head-restrained mice. All neuronal subdivisions had 
heterogeneous levels of responsivity to the onset and termination of spontaneous movements. 
Therefore, the molecular and genetic differences between the prototypic populations will not be 
the only subdivision necessary to delineate their functional contributions. Emerging evidence 
suggests that the connectivity of neurons within cell-types may provide unparalleled access into 
their functional ramifications (Lerner et al., 2016).  
4.1.3 Probing Diversity in Axonal Projections 
 The ability to map the input/output relationship of neurons provides a great deal of 
information regarding their connectivity and potential for functional contribution (Lerner et al., 
2016). Utilizing transgenic mice and viral expression of fluorescent probes, we confirmed the 
wide-spread connectivity of GPe neurons with targets within and outside of the basal ganglia 
(Mastro et al., 2014). Previously, single-cell tracing of GPe neurons showed that a single neuron 
is capable of sending collaterals to multiple brain regions (Bevan et al., 1998). But do some 
 88 
pallidal neurons project to all basal ganglia targets while others selectively innervate one or two 
targets?  
 
 
Figure 4-1 Retrograde opsin or indicator expression 
Specific stimulation or observation of a projection can also be achieved by using a retrograde virus such as rabies, 
HSV, or CAV to express an opsin or activity indicator only in cells that have a specific efferent target. In this case, 
cell bodies may be illuminated directly. Adapted from Lerner et al. (2016), with permission 
 
With recent advancements in retrograde expression of viral constructs (Figure 4-1), we have the 
capacity to break down current cell-types based on their projection targets and monitor or 
manipulate these projections selectively (Lerner et al., 2016).  
The identification of projection specific populations will provide clarity in their 
physiological response during movement. Recently, there were no clear physiological differences 
observed in response to self-generated movements within any given prototypic delineation 
(Dodson et al., 2015), but as noted above, further delineations may occur within any given cell-
type. In a recent study, cell-type diversity in the internal segment of the globus pallidus was 
shown to have an impact on the processing of limbic and sensorimotor output of the basal 
ganglia (Wallace et al., 2017). In this study, cell-types were defined within the GPi and found to 
have distinct projections to thalamic targets. Moreover, upon retrograde analysis of the inputs, 
Lhx6-GPe neurons projected to the limbic GPi territory while PV-GPe neurons projected to the 
sensorimotor GPi territory (Wallace et al., 2017). This pathway specificity is a prime example of 
 89 
how diversification of neuronal cell-types can be used to organize the functional and anatomical 
segregation that leads, in theory, to more efficient neural processing.  
Future studies can utilize these technologies to observe the dynamics of GPe neurons 
based on what and how many output targets they are connected to. How different does a PV to 
STN only neuronal population act in comparison to PV to SNr only? Moreover, exploration of 
their inputs will provide insights into how the GPe is tied into the circuit at large. These 
differences will shed light on the GPe’s widespread inhibitory connections and their impact on 
circuit dynamics.  
4.1.4 Cellular Controversy 
There has been considerable controversy on the use of Lhx6 as a marker for pallidal neurons 
(Mastro et al., 2014, Abdi et al., 2015, Dodson et al., 2015, Hernandez et al., 2015, Hegeman et 
al., 2016). Lhx6 is a homeobox protein expressed in the medial ganglionic eminence (MGE) 
during development. The MGE is the origin of most forebrain GABAergic interneurons (Marin 
et al., 2000, Cobos et al., 2006) as well as GPe neurons (Flandin et al., 2010, Nobrega-Pereira et 
al., 2010). In the GPe, all prototypical neurons express Lhx6 early in development (Dodson et 
al., 2015) but it is unclear why there is a subset of neurons that express Lhx6 into adulthood. 
Therefore, all prototypical neurons, regardless of their expression of PV or Nkx2.1, will have 
expressed Lhx6 during development. This observation does not conflict with Lhx6 being a 
marker of a distinct population of neurons in adulthood (Mastro et al., 2014) but rather increases 
the need to understand the role of homeobox proteins after development. Previous work has 
indicated the expression of these proteins as critical for the specification and maintenance of 
cellular phenotypes (Thor et al., 1991).  
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The expression of Lhx6 in adulthood has been linked to distinct functions within other 
subcortical nuclei (Choi et al., 2005). Specifically, it was found to represent a population of 
neurons critical for reproductive behaviors in the amygdala-hypothalamic pathway (Choi et al., 
2005). Though there is no evidence to support a similar functional relevance within the GPe, it 
clearly shows Lhx6 expression in adulthood as a marker for a functional distinct population of 
neurons. In Chapter 3, Lhx6 suppression is a necessary component for the induction of the motor 
rescue and therefore defines Lhx6 as a functional relevant population to investigate. 
Interestingly, the expression of PV and Nkx2.1 has not produced robust functional distinctions 
within the prototypic populations (Dodson et al., 2015) but their validity as cellular markers is 
not challenged. Together, the results highlight the complexity of GPe neural processing that will 
be the focus of many future studies on the interaction of these neural cell-types in health and 
disease.   
Future studies can capitalize on intersection approaches that grant access to each distinct 
and overlapping subdivision. For example, to assess the differences between PV+/Lhx6-, 
PV+/Lhx6+ and PV-/Lhx6+, we can breed the newly developed PV-flp (flp-dependent system, 
in contrast to cre-recombinase) with the Lhx6-cre mouse lines.  Utilizing the suite of new viral 
constructs, you can identify or manipulate each of these cellular divisions and delineate their 
anatomic and functional contributions. In the years to come, there will be greater opportunities to 
selectively label neurons across a range of factors and understand how each neuronal cell-type 
contributes to function.   
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4.2 MECHANISMS FOR LONG-LASTING THERAPEUTIC INTERVENTION 
In Parkinson’s disease, patients experience a range of symptoms including primary 
(bradykinesia, tremor and rigidity) and secondary (freezing and uncontrolled accelerations) 
motor impairments. Associated with these dysfunctions, firing rates of GPe neurons in 
Parkinson’s patients are severely diminished and the synchrony across cortical and subcortical 
(especially GPe and STN) brain regions is amplified (Nini et al., 1995, Plenz and Kital, 1999, 
Raz et al., 2000, Bevan et al., 2002, Levy et al., 2002, Terman et al., 2002). The role of the GPe 
is unknown but due to anatomic connectivity with all major basal ganglia nuclei, detrimental 
relationship with the STN (Galvan and Wichmann, 2008, Mallet et al., 2008, Tachibana et al., 
2011) and the success of stimulating the GPe during deep brain stimulation (Vitek et al., 1998, 
Yelnik et al., 2000, Vitek et al., 2004, Vitek et al., 2012), the GPe is believed to be a major 
player in basal ganglia dysfunction.  
The induction of a long-lasting rescue in the motor function of dopamine-depleted mice 
was dependent on the elevation of the PV-GPe population relative to the Lhx6-GPe. After the 
successful optogenetic manipulations (PV-ChR2, Lhx6-Arch), pathological activity within the 
basal ganglia output nucleus was attenuated for hours and hours after stimulation. The following 
section will explore, in greater detail, the possible mechanisms of induction and how current 
treatments may be refined or developed to capitalize on the latest findings. 
4.2.1 State-Dependent Shifts 
Disruptions in the pathological activity are correlated with successful pharmacological and 
surgical interventions dependent on the continuous administration of selected treatment. As 
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discussed in the introduction, prolonged usage often lead to negative side effects that impede the 
treatment of Parkinson’s patients. Therefore, identifying the characteristics of the optical 
manipulation that are necessary for the long-lasting recovery may produce novel therapies that 
extend well after their administration.  
 Recently, there have been advancements in the protocols of deep brain stimulation (DBS) 
that has provided relief not only during stimulation but for days and days afterward in both 
MPTP primate models (Tass et al., 2012, Wang et al., 2016) and a proof of concept for human 
PD patients (Adamchic et al., 2014). This new procedure is known as coordinated reset (CR) – 
DBS and utilizes the four contacts on the DBS electrode to destabilize the network (Figure 4-
2A). In theory, traditional DBS, stimulating with all contacts simultaneously within target region, 
modulates the activity of neurons, astrocytes, and axonal projections that act to break 
pathological activity only transiently. As shown in Figure 4-2, CR-DBS posits that each lead 
comes into contact with a unique space in the brain and by electrically stimulating at each 
contact individually and at set intervals; you are modulating each of the areas independently 
(Popovych and Tass, 2012). This leads to a desynchronization of the underlying processes that 
kicks the circuit out of its detrimental rhythm and allows for relief of Parkinsonian deficits.  
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Figure 4-2 Stimulation setup for electrical stimulation. 
(A) Schematic localization of four stimulation sites within the neuronal population and the corresponding spatial 
profiles of current decay in the neuronal tissue with the distance from the stimulation site. (B) Stimulation signals of 
electrical CR stimulation composed of short pulse trains of charge-balanced pulses. From (Popovych and Tass, 
2012) Popovych and Tass (2012), with permission. 
 
 This model has many parallels to our recent discovery that cell-type specific but not 
global manipulations rescue motor function. Global manipulations, either activation or 
suppression, of GPe activity had no therapeutic benefit and may be due to the lack of 
desynchronization within the network. This was evident in the recordings of activity within the 
basal ganglia output nucleus where the percentage of highly ‘bursty’ neurons did not decrease 
after global GPe activation and in some cases increased shortly after. In contrast, the successful 
optogenetic manipulations (PV-ChR2, Lhx6-Arch) were able to transiently dissociate activity 
within the GPe and destabilize the network hours after. Unlike CR-DBS that relies heavily on the 
spatially distinct populations of neurons, the optogenetic GPe approach utilizes distinct 
population of neurons that are often interweaved spatially through the GPe. 
To achieve dissociation of these neuronal populations without the aid of opotogenetics, 
there are two avenues that are clinically beneficial to follow. Firstly, stereological evidence has 
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confirmed the presence of PV-GPe neurons in humans at roughly the same percentage as 
observed in mice and rodents (Hardman and Halliday, 1999). Utilizing drop-seq analysis of RNA 
expression, there are groups working to understand how these neurons differ from other GPe 
cell-types. In doing so, this analysis will provide a list of potential targets for drug development 
that would selectively modulate the activity of these neurons relative to other neuronal 
populations.  
The second avenue may be the refinement of current DBS targeting strategies that 
capitalize on the potential gradient of PV-GPe neurons that may exist. We found that PV-GPe 
neurons are enriched within the lateral aspect of the GPe and therefore may contain functionally 
important differences than other areas. As discussed previously, previous studies have shown 
that focal activation with the GPe provide distinct alterations to behavior (Matsumura et al., 
1995, Grabli et al., 2004). Furthermore, these territories receive distinct sets of inputs from the 
striatum and STN (Francois et al., 2004). Therefore, further analysis of cell-type specific roles 
within discrete GPe territories would provide clarity into their functional contributions in health 
and disease.  
4.2.2 STN-Mediated Mechanisms 
The STN-GPe complex is implicated in the onset and propagation of harmful synchrony within 
the Parkinsonian basal ganglia (Bevan et al., 2002). Due to the reciprocity and differences in 
neurotransmitter (STN: Glutamate, GPe: GABA), the relationship between GPe and STN form a 
critical node within the basal ganglia in health (Mirzaei et al., 2017) and disease (Bevan et al., 
2002, Galvan and Wichmann, 2008, Mallet et al., 2008, Tachibana et al., 2011). Moreover, the 
synaptic weight and oscillatory tendencies of the GPe and STN are significantly altered in 
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disease (Plenz and Kital, 1999, Brown et al., 2001, Bevan et al., 2002, Rubin and Terman, 2004, 
Baufreton et al., 2005, Mallet et al., 2008, Fan et al., 2012, Fujita et al., 2012, Chu et al., 2015).  
A recent study revealed a form of heterosynaptic plasticity that strengthens the GPe to 
STN synapses due to the recruitment of postsynaptic GABA receptors and the enhancement of 
presynaptic release (Fan et al., 2012, Chu et al., 2015). As discussed in Mastro and Gittis (2015), 
the heterosynaptic plasticity may act as a homeostatic mechanism that balances the contributions 
of inhibition and excitation in response to changes in internal (i.e. amount of dopamine, 
excessive cortical modulation) and external (i.e. learning, development) condition. The 
mechanism may be engaged over the course of dopamine loss and responsible for compensation 
that defers the onset of motor deficits until the majority of dopamine is lost. Moreover, upon 
significant changes pathophysiology, the mechanism is hijacked and becomes highly detrimental 
to circuit function. Therefore, changes in the GPe-STN relationship that shifts the balance of 
these two pathways may be responsible for the attenuation of pathological activity that was 
observed after the successful optogenetic manipulations.  
The distinct pattern of STN innervation by PV- and Lhx6-GPe may be a contributing 
factor for successful induction of behavioral rescue (Mastro et al., 2014).  As noted above, the 
basal ganglia contains parallel circuits that include ‘motor’, ‘limbic’ and ‘associative’ functions 
and are topographically segregated(Alexander et al., 1986, Middleton and Strick, 2000). While 
~80% of GPe neurons project to the STN, subpopulations of GPe neurons innervate the STN 
differently. PV-GPe neurons project to the full extent of the STN while Lhx6-GPe neurons do 
not project to the central territory (see Fig. 2-4). This may correspond to the sensorimotor 
territory of the STN (Parent and Hazrati, 1995). Some evidence was provided indirectly by Chu 
et al. (2015) where virally-transfected axonal arborization from the motor cortex innervated the 
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central region of the STN. Baron et al. (2002) found that focal inactivation of the STN or GPi 
were sufficient to for the amelioration of Parkinsonian motor deficits. Moreover, the targeting of 
DBS electrodes is most effective within the sensorimotor region of either the STN or GPe 
(Wichmann and DeLong, 2016). Interestingly, optical activation of afferents to the STN 
provided a strong amelioration of PD deficits that was not observed upon direct activation of the 
STN neurons (Gradinaru et al., 2009). Together, these data indicate that modulation of the 
sensorimotor pathway, irrespective of STN neuronal activation, is sufficient to rescue motor 
function in animal models of PD.  
To assess whether the behavioral induction is altering the GPe-STN network, future 
experiments should record simultaneously in the GPe and STN during and after the optogenetic 
manipulation. Secondly, if a form of plasticity is occurring, slices should be prepared shortly 
after the induction of the behavioral rescue and measured ex vivo. Together, these would provide 
the evidence necessary to implicate the GPe-STN as a critical node in the induction of the long-
lasting recovery. If possible and with the advent of optical proteins capable of avoiding back-
propagating action potentials, it would be interesting to ask if the excitation of PV-GPe or 
inhibition of Lhx6-GPe terminals within the STN is sufficient to induce the behavioral rescue. 
4.3 FINAL REMARKS 
In conclusion, the GPe is complex. It does, like most brain regions, contain a diverse set of cell-
types that must be identified, appreciated and incorporated into models of circuit function. Our 
first contribution was the identification of distinct populations of GPe neurons utilizing 
transgenic mice. These mice provide an opportunity to exploit the proliferation of tools to 
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identify and manipulate across experimental conditions. These tools will be used in future studies 
to gain unparalleled access to GPe’s complexity. From measuring the strength and influence of 
every connection, to identifying cell-type specific forms of plasticity, to perturbing brain and 
circuit dynamics as you image or record 1000s of identifiable neurons and learn how they 
respond and adapt; these cell-type delineations will alter the way we understand GPe function.  
Our second contribution focused on harnessing these cell-types to treat neurological 
disorders. This study demonstrates the first evidence for cell-type specific intervention within the 
GPe that induces a robust and long-lasting recovery of movement. These results provide 
evidence for the utility of and the need for the development of GPe specific interventions. 
Although we do not know the mechanism of action, the GPe is a central node for pathological 
activity during PD (Bergman et al., 1998, Bevan et al., 2002, Kita, 2007, Holgado et al., 2010, 
Vitek et al., 2012, Corbit et al., 2016). Our data identify PV and Lhx6-GPe neurons as critical 
nodes within the basal ganglia circuit for the induction of long-lasting attenuation of pathological 
activity in the SNr. Moving forward, elucidating the cell-type specificity of GPe’s influence on 
circuit function will provide a great benefit to both the basic understanding of basal ganglia 
function and the GPe’s ability to treat neurological disorders. 
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APPENDIX A 
 
Figure A1 Behavioral and pathophysiological sympotoms of bilateral DD are apparent within 3-5 d post-
depletion 
(a) Schematic of bilateral DD in the medial forebrain bundle (MFB). (b) Quantification of immobility and 
bradykinesia induced by unilateral (Uni, n = 4) and bilateral (Bi, n = 51) depletions, as compared to dopamine-intact 
controls (Naive, n = 4). (*p < 0.02, **p < 0.001, Mann Whitney U). (c) Rasters of single units in the GPe of naïve 
vs. bilateral DD mice. Scale bar, 500 ms. (d) Box plots showing decreases in firing rates (Naive: 44.3 ± 2.6 Hz, n = 
73 across 4 animals, versus Acute: 24.6 ± 1.6 Hz,n = 62 across 3 animals, H(1) = 29.775, **p < 0.001, Kruskal-
Wallis H test) and (e) increases in coefficients of variation of the interspike intervals (CVISI) (Naïve: 0.63 ± 0.03 
versus Acute: 0.80 ± 0.03, H(1) = 22.615, *p < 0.001, Kruskal-Wallis H test) following bilateral DD. Error bars, 
sem. 
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Figure A2 Histological verification of TH immunoreactivity, viral expression and fiber placements for behavioral optogenetics in global manipulations. 
(a) Representative images of striatal TH immunoreactivity in dorsal striatum of healthy dopamine intact tissue compared to a fully depleted bilateral animal. 
Scale Bar, 200 μm (b) Epifluorescent images of viral expression and fiber identification (yellow arrow) within the GPe. Scale Bar, 500 μm (c) Superimposed 
traces of viral expression across animals within hSyn-ChR2 (d) Epifluorescent images of viral expression and fiber identification (yellow arrow) with the dorsal 
striatum. Scale Bar, 500 μm (e) Superimposed traces of viral expression across animals within D1-ChR2 condition. Ctx = Cortex, Str = Striatum, GPe = globus 
pallidus externa. 
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Figure A3 Histological verification of viral expression and fiber placements for behavioral optogenetics in cell-type manipulations. 
 (a) Epifluorescent images of viral expression and fiber identification (yellow arrow) within the GPe. Scale Bar, 500 μm (b-f) Superimposed traces of viral 
expression across animals within PV-ChR2, Lhx6-Arch, CAG-Arch, Lhx6-ChR2 and PV-Arch conditions. 
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Figure A4 PV-ChR2 stimulation induces transient effects in partially and unilaterally depleted mice. 
(a) Percentage of time spent in the immobile state before, during and after PV-ChR2 stimulation in 
lipopolysaccharide (LPS) injected mice. (b) Schematic representation of striatal location for TH analysis with 
epifluorescent image of a partial depletion of tyrosine hydroxylase. Scale Bar, 200 μm. (c) Quantification of TH 
levels, normalized to dopamine intact littermate and subsequent categorization into partially and fully depleted 
animals.(d) Percentage of time spent in the immobile state before, during, and after PV-ChR2 stimulation in 
partially depleted mice. (e) Overlay of immobility immediately before (pre), during (stim), and after (post) each light 
pulse. (f) Percent time spent immobile for each animal (grey x = pre, black circle = post) and degree of rescue (red 
line) as a function of TH remaining. Note sharp cut-off for induction of behavioral rescue at ~20% dopamine 
remaining. (g) Percentage of time spent in the immobile state before, during, and after PV-ChR2 stimulation in 
unilaterally depleted mice. (h) Overlay of immobility immediately before (pre), during (stim), and after (post) each 
light pulse. (i) Percent time spent immobile over the course of the full experimental trial. Error bars, sem. 
 
 
 
 
 
 
 
 
 
 102 
 
Figure A5 Optical identification using ChR2 and Arch and their corresponding firing properties and 
waveforms.  
(a) Representative responses over 20 trials from a ChR2+ (putative PV) and CHR2- (putative non-PV) neuron 
responding to 5 ms optical pulses. Yellow bar denotes first significant bin as compared to baseline (b) Firing rate 
and coefficient of variation of the interspike interval (CVISI) for ChR2+ and ChR2- neurons in dopamine depleted 
(FR: p = 0.128, CVISI: p = 0.005, Mann Whitney U) (c) Extracellular waveform analysis of the peak-valley ratio and 
amplitude of individual units identified as ChR2+ (red, closed circles) and ChR2- (black, open circles). Inset: 
Average waveforms of ChR2+ and ChR2- (Note: nearly complete overlap). Scale bar: 50 μV(vertical), 220 μsec 
(horizontal) (d) Firing rate and coefficient of variation of the interspike interval (CVISI) for ChR2+ and ChR2- 
neurons in dopamine intact animals (Naïve) (e) Representative responses over 20 trials from a Arch+ (putative 
Lhx6) and Arch- (putative non-Lhx6) neuron responding to 1 s optical pulses. (f) Firing rate and CVISI for Arch+ 
and Arch- neurons (FR: p = 0.990, CV: p = 0.454, Mann Whitney U). (g) Extracellular waveform analysis of the 
peak-valley ratio and amplitude of individual units identified as Arch+ (blue, closed squares) and Arch- (black, open 
squares). Inset: Average waveforms of Arch+ and Arch-. Scale bar: 50 μV(vertical), 220 μsec (horizontal). 
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Figure A6 PV and Lhx6 overlap partially in the Lhx6-Cre transgenic mouse. 
(a) Fluorescent images from the GPe showing overlap between Lhx6-iCre and PV. Left: Lhx6-EYFP neurons. 
Arrows denote position of PV+ neurons (Purple arrows: Lhx6/PV double labeled; Red arrows: PV-only neurons). 
Note weaker Lhx6-EYFP expression in Lhx6/PV neurons. Middle: PV+ neurons (Blue arrows: Lhx6-only neurons). 
Right: Overlay. (b) Box diagram summarizing the proportion of GPe neurons (n = 4194 total neurons across 5 
animals) counted that expressed either PV, Lhx6, or both. 
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Figure A7 SNr firing rate is unaltered after PV-ChR2 and Lhx6-Arch, but decreased after hSyn-ChR2 
manipulation.  
(a) Firing rate of single units collected before (pre) and after (post) stimulation in PV-ChR2 (nPre = 80 vs nPost = 58 
units across 3 animals, p = 0.976, Mann Whitney U), hSYn-ChR2 (nPre = 55 vs nPost = 69 unit across 3 animals, p = 
0.002, Mann Whitney U) and Lhx6-Arch (nPre = 30 vs nPost = 69 units across 3 animals, p = 0.142, Mann Whitney 
U). 
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APPENDIX B 
Figure B1 Video 1: PV-ChR2 fast speed 
Accelerated recording of a representative PV-ChR2 animal throughout the course of stimulation 
http://www.nature.com/neuro/journal/v20/n6/fig_tab/nn.4559_SV1.html  
 
Figure B2 Video 2: PV-ChR2 HD 
High Definition recording of PV-ChR2 condition with representative clips from early stimulation, late stimulation 
and hours after stimulation. 
http://www.nature.com/neuro/journal/v20/n6/fig_tab/nn.4559_SV2.html  
 
Figure B3 Video 3:Lhx6-Arch fast speed 
Accelerated recording of a representative Lhx6-Arch animal throughout the course of stimulation 
http://www.nature.com/neuro/journal/v20/n6/fig_tab/nn.4559_SV3.html  
 
Figure B4 Video 4: Lhx6-Arch HD 
High Definition recording of Lhx6-Arch condition with representative clips from early stimulation, late stimulation 
and hours after stimulation. 
http://www.nature.com/neuro/journal/v20/n6/fig_tab/nn.4559_SV4.html  
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